###begin article-title 0
A novel genetic strategy reveals unexpected roles of the Swi-Snf-like chromatin-remodeling BAF complex in thymocyte development
###end article-title 0
###begin p 1
###xml 25 42 25 42 <email xmlns:xlink="http://www.w3.org/1999/xlink">Tian.Chi@yale.edu</email>
CORRESPONDENCE Tian Chi: Tian.Chi@yale.edu
###end p 1
###begin p 2
This article is distributed under the terms of an Attribution-Noncommercial-Share Alike-No Mirror Sites license for the first six months after the publication date (see ). After six months it is available under a Creative Commons License (Attribution-Noncommercial-Share Alike 3.0 Unported license, as described at ).
###end p 2
###begin p 3
###xml 542 550 542 550 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Immunity</italic>
###xml 804 807 804 807 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CD4</italic>
We have developed a general strategy for creating littermates bearing either a tissue-specific point mutation or deletion in any target gene, and used the method to dissect the roles of Brg, the ATPase subunit of the chromatin-remodeling Brg-associated factor (BAF) complex, in early thymocyte development. We found that a point mutation that inactivates the Brg ATPase recapitulates multiple defects previously described for Brg deletion (Chi, T.H., M. Wan, P.P. Lee, K. Akashi, D. Metzger, P. Chambon, C.B. Wilson, and G.R. Crabtree. 2003. Immunity. 19:169-182). However, the point mutant helps reveal unexpected roles of Brg in CD25 repression and CD4 activation. Surprisingly, CD4 activation occurs independently of the Brg ATPase and is perhaps mediated by physical interactions between Brg and the CD4 locus. Our study thus suggests that the BAF complex harbors novel activities that can be necessary and even sufficient for stimulating transcription from an endogenous chromatin template in the absence of Brg-dependent remodeling of that template. We conclude that conditional point mutants, rarely used in mammalian genetics, can help uncover important gene functions undetectable or overlooked in deletion mutants.
###end p 3
###begin p 4
Abbreviations used: BAF, Brg-associated factor; DN, double negative; DP, double positive; ES, embryonic stem; IRES, internal ribosome entry site; ISP, immature SP; LCR, locus control region; SA, splice acceptor; SP, single positive.
###end p 4
###begin p 5
M. Wan, J. Zhang, and K. Cui contributed equally to this paper.
###end p 5
###begin p 6
J. Zhang's present address is Institute for Cell Engineering, Johns Hopkins University School of Medicine, Baltimore, MD 21205.
###end p 6
###begin p 7
###xml 154 155 140 141 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib1">1</xref>
###xml 596 599 579 582 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CD4</italic>
###xml 613 614 596 597 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 617 618 600 601 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 647 648 630 631 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib2">2</xref>
###xml 709 712 685 688 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CD4</italic>
###xml 716 719 692 695 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CD8</italic>
###xml 820 821 796 797 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib3">3</xref>
Intrathymic development of T lymphocytes bearing alphabeta antigen receptor (TCRalphabeta) is one of the best-defined ontogenetic systems in vertebrates (1). The earliest T cells express neither CD4 nor CD8 and are known as double-negative (DN) cells. DN cells pass through four successive stages (DN1-4), as defined by differential expression of CD25 and CD44. Cells at the DN3 stage recombine the TCRbeta gene to express a pre-TCR complex that propels DN3 cells into the DN4 stage. DN4 cells activate CD8 transcription to become immature single-positive (ISP) cells that subsequently derepress CD4 to become CD4+CD8+ double-positive (DP) cells (2). DP cells displaying proper TCRalphabeta extinguish either CD4 or CD8 expression and mature into CD8 or CD4 SP cells, respectively, before their export to the periphery (3).
###end p 7
###begin p 8
###xml 456 457 456 457 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib4">4</xref>
###xml 587 588 587 588 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib5">5</xref>
###xml 902 903 890 891 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib6">6</xref>
###xml 964 965 952 953 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib7">7</xref>
###xml 1184 1185 1172 1173 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib8">8</xref>
###xml 1187 1188 1175 1176 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib9">9</xref>
###xml 564 569 <span type="species:ncbi:4932">yeast</span>
The execution of transcriptional programs during development relies on precise temporal- and spatial-specific regulation of gene expression, which in turn requires the modulation of chromatin structure of target genes. An important class of enzymes capable of manipulating chromatin structure is the "chromatin-remodeling complexes," the multisubunit molecular motors that use energy derived from ATP hydrolysis to physically disrupt histone-DNA contacts (4). The best-known chromatin remodeler in mammals is the Brg-associated factor (BAF) complex related to the yeast Swi-Snf complex (5). The BAF complex contains approximately10 subunits, including the ATPase Brg or its homologue Brm. In addition to Brg/Brm, several other subunits of the BAF complex are encoded by gene families, thus leading to the combinatorial assembly and generation of perhaps hundreds of complexes with divergent functions (6). The BAF complex plays diverse roles in the immune system (7) and is essential for early T cell development, because Brg deletion in DN2, DN3, and DN4 cells impairs their survival, proliferation, and developmental transitions, and causes premature CD4 expression on these cells (8, 9).
###end p 8
###begin p 9
###xml 388 390 388 390 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib10">10</xref>
###xml 392 394 392 394 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib11">11</xref>
###xml 649 651 649 651 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib12">12</xref>
###xml 793 795 793 795 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib13">13</xref>
###xml 1358 1360 1358 1360 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib14">14</xref>
###xml 479 504 <span type="species:ncbi:11757">mouse mammary tumor virus</span>
Although the BAF complex can remodel chromatin, it might have functions in gene regulation beyond classical ATP-dependent remodeling, as suggested by the following data. Specifically, the ATPase activity of Brg and, therefore, chromatin remodeling by the BAF complex is critically dependent on a lysine residue (K785) located in the nucleotide-binding pocket of the ATPase domain of Brg (10, 11). Remarkably, although the ATPase-dead Brg mutant Brg (K785R) fails to activate the mouse mammary tumor virus promoter integrated into the genome of a Brg-deficient cell line, it efficiently stimulates the same promoter in transient transfection assays (12). In contrast to the stably integrated promoter that is organized into nucleosomes, the transiently transfected promoter is nucleosome free (13), which apparently circumvents the need for ATP-dependent remodeling, thus revealing the potential of the BAF complex to activate transcription independently of Brg ATPase activity, although the data interpretation is confounded by the fact that Brg (K785R) was overexpressed in that study. The existence of the putative novel activities of the BAF complex unrelated to Brg-catalyzed remodeling is consistent with the fact that although the BAF complex consists of 10 subunits, 4 subunits (including Brg) are fully sufficient for nucleosome disruption in vitro (14), which suggests that the remaining "dispensable" subunits may harbor the novel activities. In addition, Brg itself may also harbor such activities in regions outside its ATPase domain.
###end p 9
###begin p 10
###xml 196 198 196 198 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib15">15</xref>
###xml 250 252 250 252 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib15">15</xref>
###xml 372 374 372 374 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib16">16</xref>
###xml 513 515 513 515 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib17">17</xref>
###xml 517 519 517 519 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib18">18</xref>
These data raise the question of whether the phenotype seen in Brg-deleted thymocytes specifically reflects defects in chromatin remodeling. Brg is essential for the integrity of the BAF complex (15), for tethering the BAF complex to nuclear matrix (15), for recruiting the BAF complex to certain target genes via interaction with sequence-specific transcription factors (16), and presumably for stable association of the BAF complex with chromatin via its bromodomain and a region rich in lysines and arginines (17, 18). Thus, Brg deletion may have completely eliminated the functions of the entire BAF complex, suggesting that the phenotype in Brg-deleted cells reflects both ATPase-dependent and -independent roles of the BAF complex in gene regulation.
###end p 10
###begin p 11
###xml 132 136 <span type="species:ncbi:10090|species:ncbi:10095">mice</span>
###xml 200 204 <span type="species:ncbi:10090|species:ncbi:10095">mice</span>
###xml 246 250 <span type="species:ncbi:10090|species:ncbi:10095">mice</span>
To test whether Brg has ATPase-independent activity and to dissect the complex phenotype seen in Brg deletion mutants, we generated mice bearing a thymocyte-specific Brg (K785R) point mutation. These mice were produced within the same litters as mice lacking Brg in thymocytes, allowing for direct phenotypic comparison. We found that Brg ATPase is generally required for Brg function, but Brg does have an unexpected, ATPase-independent role in CD4 regulation that is obscured in the Brg deletion mutant. Brg point mutation also reveals a role of Brg in CD25 regulation not detected in the Brg deletion mutant.
###end p 11
###begin title 12
RESULTS
###end title 12
###begin title 13
Generation of littermates bearing a thymocyte-specific Brg point mutation or Brg deletion
###end title 13
###begin p 14
###xml 49 50 49 50 <sup xmlns:xlink="http://www.w3.org/1999/xlink">O</sup>
###xml 309 317 309 317 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig1" ref-type="fig">Fig. 1 A</xref>
###xml 806 814 806 814 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig1" ref-type="fig">Fig. 1 H</xref>
###xml 1033 1041 1033 1041 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig1" ref-type="fig">Fig. 1 A</xref>
###xml 1077 1078 1077 1078 <sup xmlns:xlink="http://www.w3.org/1999/xlink">O</sup>
###xml 1117 1120 1117 1120 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Brg</italic>
###xml 1120 1121 1120 1121 <sup xmlns:xlink="http://www.w3.org/1999/xlink">F</sup>
###xml 1131 1132 1131 1132 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib8">8</xref>
###xml 1134 1136 1134 1136 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib19">19</xref>
###xml 1227 1235 1227 1235 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig1" ref-type="fig">Fig. 1 B</xref>
###xml 1238 1240 1238 1240 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib20">20</xref>
###xml 1323 1326 1323 1326 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Brg</italic>
###xml 1326 1327 1326 1327 <sup xmlns:xlink="http://www.w3.org/1999/xlink">O</sup>
###xml 1332 1335 1332 1335 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Brg</italic>
###xml 1335 1336 1335 1336 <sup xmlns:xlink="http://www.w3.org/1999/xlink">F</sup>
###xml 1520 1523 1520 1523 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Brg</italic>
###xml 1523 1526 1523 1526 <sup xmlns:xlink="http://www.w3.org/1999/xlink">F/F</sup>
###xml 1553 1556 1553 1556 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Brg</italic>
###xml 1556 1559 1556 1559 <sup xmlns:xlink="http://www.w3.org/1999/xlink">F/F</sup>
###xml 1574 1577 1574 1577 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Brg</italic>
###xml 1577 1580 1577 1580 <sup xmlns:xlink="http://www.w3.org/1999/xlink">F/O</sup>
###xml 1682 1690 1682 1690 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig1" ref-type="fig">Fig. 1 B</xref>
###xml 1057 1061 <span type="species:ncbi:10090|species:ncbi:10095">mice</span>
###xml 1252 1256 <span type="species:ncbi:10090|species:ncbi:10095">mice</span>
###xml 1471 1475 <span type="species:ncbi:10090|species:ncbi:10095">mice</span>
###xml 1536 1540 <span type="species:ncbi:10090|species:ncbi:10095">mice</span>
We first generated a bifunctional Brg allele (BrgO) that is normally a null allele but can be conditionally turned into the point mutant allele expressing the Brg (K785R) protein. Specifically, we introduced K/R point mutation into the exon that encodes part of the ATP-binding site in the Brg ATPase domain (Fig. 1 A). At the same time, we placed, downstream of the mutant exon, a removable promoter-trapping cassette consisting of a splice acceptor (SA) and the neomycin resistance gene (Neo). Upon splicing, the promoter-trapping cassette captures the mutant exon, leading to the production of a fusion protein between the N terminus (aa 1-813) of Brg and Neo. This fusion protein is unstable and, therefore, does not act as a dominant negative to interfere with the function of the WT Brg protein (see Fig. 1 H), but it can be converted into the full-length Brg (K/R) protein upon Cre-mediated excision of the gene-trapping cassette and subsequent restoration of correct splicing between the mutant exon and the downstream exon (Fig. 1 A). We then bred mice bearing the BrgO allele, the "traditional" floxed Brg (BrgF) allele (8, 19), and the transgene expressing Cre in thymocytes from the LCK-proximal promoter (LCK-Cre; Fig. 1 B) (20). In these mice, nonthymocytes express Brg (1-813)-Neo fusion and WT Brg from the BrgO and BrgF alleles, respectively, whereas in thymocytes, the fusion is converted into the Brg (K/R) point mutant and WT Brg is eliminated. These mice can be generated within the same litters as BrgF/F; LCK-Cre mice by crossing BrgF/F; LCK-Cre with BrgF/O, thus allowing direct comparison of the phenotypes caused by Brg point mutation versus Brg deletion (Fig. 1 B).
###end p 14
###begin p 15
###xml 0 53 0 53 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Generation of conditional Brg (K785R) point mutation.</bold>
###xml 132 135 132 135 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Brg</italic>
###xml 360 363 360 363 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Brg</italic>
###xml 363 364 363 364 <sup xmlns:xlink="http://www.w3.org/1999/xlink">O</sup>
###xml 409 412 409 412 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Brg</italic>
###xml 421 424 421 424 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Brg</italic>
###xml 424 425 424 425 <sup xmlns:xlink="http://www.w3.org/1999/xlink">F</sup>
###xml 522 525 522 525 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Brg</italic>
###xml 695 698 695 698 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Brg</italic>
###xml 1128 1131 1128 1131 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Brg</italic>
###xml 1131 1132 1131 1132 <sup xmlns:xlink="http://www.w3.org/1999/xlink">F</sup>
###xml 1159 1167 1159 1167 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig2" ref-type="fig">Fig. 2 B</xref>
###xml 1173 1188 1173 1188 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig3" ref-type="fig">Fig. 3, E and F</xref>
###xml 1249 1252 1249 1252 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Brg</italic>
###xml 1252 1253 1252 1253 <sup xmlns:xlink="http://www.w3.org/1999/xlink">F</sup>
###xml 322 326 <span type="species:ncbi:10090|species:ncbi:10095">mice</span>
###xml 535 539 <span type="species:ncbi:10090|species:ncbi:10095">mice</span>
###xml 908 912 <span type="species:ncbi:10633?0.9966199903428296">SV40</span>
Generation of conditional Brg (K785R) point mutation. (A) A removable promoter-trapping cassette is used to generate a bifunctional Brg allele that is normally a null allele but is converted into the point mutant allele expressing Brg(K785R) upon Cre expression. (B) Brg (K785R) is specifically expressed in thymocytes in mice bearing the bifunctional allele (BrgO) in combination with the traditional floxed Brg allele (BrgF) and LCK-Cre (left). The phenotypes are then compared with that seen in traditional conditional Brg knockout mice (right) to reveal a potential ATPase-independent function of the BAF complex during T cell development. (C) Targeting strategy. Four relevant exons in the Brg locus are depicted, arbitrarily designated E1-4. A floxed promoter-trapping cassette-consisting of an adenoviral SA, the promoterless neomycin resistant gene (Neo), IRES, a destabilized version of GFP, and an SV40 polyadenylation signal (pA)-is inserted between E2 and E3. The primers for screening ES cells (a-e) and for detecting Cre-mediated recombination (f and g) are indicated. Primers (h and i) are used for detecting the BrgF allele in thymocytes (see Fig. 2 B; and Fig. 3, E and F). Also indicated are the two exons (E3 and 4) floxed in the BrgF allele. The asterisks indicate Brg K/R point mutations. (D-H) Analysis of ES cells. The integration of left and right arms was screened by RT-PCR (D) and PCR (E), respectively. Cre-mediated recombination was confirmed by PCR (F). The targeting was confirmed with Southern blotting (G), where the genomic DNA was digested with Sca I and Not1 cutting outside and within the targeting vector, respectively, thus releasing a 5.5-kb fragment encompassing the Neo sequence. The Brg-Neo fusion protein was analyzed by Western blotting (H). Primer pairs used for RT-PCR were indicated to the right of the gel images in D-F. The asterisk in D denotes the PCR product amplified from the mRNA expressed from the bifunctional allele before E2-Neo splicing, and/or from the contaminating genomic DNA sequence. Unmodified ES cells (Ctrl) are used as controls where indicated.
###end p 15
###begin p 16
###xml 36 44 36 44 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig1" ref-type="fig">Fig. 1 C</xref>
###xml 223 226 223 226 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Brg</italic>
###xml 719 727 719 727 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig1" ref-type="fig">Fig. 1 D</xref>
###xml 760 763 760 763 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Brg</italic>
###xml 1033 1036 1033 1036 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Brg</italic>
###xml 1064 1072 1064 1072 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig1" ref-type="fig">Fig. 1 D</xref>
###xml 1377 1385 1365 1373 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig1" ref-type="fig">Fig. 1 E</xref>
###xml 1648 1651 1636 1639 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Brg</italic>
###xml 1924 1932 1912 1920 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig1" ref-type="fig">Fig. 1 F</xref>
The targeting vector is depicted in Fig. 1 C. The floxed promoter-trapping cassette contains the promoterless Neo-internal ribosome entry site (IRES)-GFP sequence downstream of an adenoviral SA. This cassette is flanked by Brg genomic sequences, the left arm being a 1.8-kb genomic fragment containing the exon (E2) bearing K/R point mutation, whereas the right arm is a 4.6-kb fragment containing another exon (E3). The vector was electroporated into embryonic stem (ES) cells, and a total of 72 colonies emerged after G418 selection, 22 of which were analyzed. Expectedly, most of the clones express RNA in which E2 is spliced to Neo, as detected by RT-PCR using primers b and c recognizing E2 and Neo, respectively (Fig. 1 D, top). To determine whether the Brg locus has been targeted, RT-PCR was performed using primers a and c, the former recognizing an exon (E1) not present in the targeting vector. Clones #5 and #14 expressed RNA that contains E1 spliced to Neo, indicating that the left arm is correctly recombined into the Brg locus in these two clones (Fig. 1 D, bottom). To check the integration of the right arm, DNA from these two clones was subjected to PCR using primers d and e, the latter recognizing an exon (E4) not present in the vector. An amplicon of the expected size (approximately5 kb) was obtained, indicating correct recombination of the right arm (Fig. 1 E). To determine whether Cre can indeed excise out the Neo-IRES-GFP cassette from the targeted locus, a Cre-expressing plasmid was electroporated into the ES cells, and the resultant DNA was analyzed by PCR using primers f and g recognizing the 5' LoxP site and a Brg genomic sequence downstream of the 3' LoxP site. Excision of the floxed promoter-trapping cassette would shorten the distance between the two primers, leading to the amplification of 170 bp DNA. Indeed, rearrangement was specifically detected in the transfected ES cells (Fig. 1 F).
###end p 16
###begin p 17
###xml 289 297 277 285 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig1" ref-type="fig">Fig. 1 G</xref>
Southern blotting using a Neo probe was performed, which confirmed that the gene-trapping cassette was correctly targeted and that there is no secondary integration of concatemers, as the latter would have generated an approximately13-kb band, the size of the linearized targeting vector (Fig. 1 G).
###end p 17
###begin p 18
###xml 239 242 239 242 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Brg</italic>
###xml 256 259 256 259 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Brg</italic>
###xml 259 260 259 260 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 333 335 333 335 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib21">21</xref>
###xml 430 433 430 433 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Brg</italic>
###xml 433 434 433 434 <sup xmlns:xlink="http://www.w3.org/1999/xlink">O</sup>
###xml 473 481 473 481 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig1" ref-type="fig">Fig. 1 H</xref>
###xml 875 878 875 878 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Brg</italic>
###xml 878 879 878 879 <sup xmlns:xlink="http://www.w3.org/1999/xlink">O</sup>
###xml 956 964 956 964 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig2" ref-type="fig">Fig. 2 A</xref>
###xml 1047 1050 1047 1050 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Brg</italic>
###xml 1050 1051 1050 1051 <sup xmlns:xlink="http://www.w3.org/1999/xlink">O</sup>
###xml 1149 1152 1149 1152 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Brg</italic>
###xml 1152 1155 1152 1155 <sup xmlns:xlink="http://www.w3.org/1999/xlink">O/+</sup>
###xml 1257 1260 1257 1260 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Brg</italic>
###xml 1260 1261 1260 1261 <sup xmlns:xlink="http://www.w3.org/1999/xlink">O</sup>
Western blotting using an antibody against the N terminus of Brg was performed to assess the level of Brg (1-813)-Neo fusion protein in the ES clones. This fusion is structurally similar to the Brg-Neo fusion expressed by the constitutive Brg null allele (Brg-), the latter known to be unstable and undetectable by Western blotting (21). Indeed, the antibody detected full-length Brg but not the fusion protein expressed from the BrgO allele that should migrate at 120 kD (Fig. 1 H), suggesting that the fusion protein is unstable and thus should not interfere with the function of WT Brg protein, although the protein must be present at some level to confer resistance to neomycin for the selection of ES cells. Alternatively, the protein may be present at a high level but still be undetectable because of masking of the Brg epitope, but this seems less likely because the BrgO allele behaves as a null allele rather than a dominant-negative allele (see Fig. 2 A). In addition, there is no evidence for alternative splicing between E2 and E3 in BrgO RNA, consistent with the fact that the mRNA bearing E2 spliced to E3 is twofold less abundant in BrgO/+ cells as compared with WT cells (Fig. S1, available at ). Collectively, these data indicate that the BrgO allele is a true null allele before the excision of the gene-trapping cassette.
###end p 18
###begin p 19
###xml 14 15 14 15 <sup xmlns:xlink="http://www.w3.org/1999/xlink">O</sup>
###xml 479 480 479 480 <sup xmlns:xlink="http://www.w3.org/1999/xlink">O</sup>
###xml 459 463 <span type="species:ncbi:10090|species:ncbi:10095">Mice</span>
GFP in the BrgO allele was intended for marking the cells that have undergone Cre-mediated excision; those cells should lose GFP expression. As GFP has a long half-life (24 h), we fused GFP to the protein degradation sequence PEST to reduce its half-life. Unfortunately, none of the ES colonies that emerged after G418 selection had visible GFP expression (unpublished data), suggesting that the rapid degradation has eliminated GFP protein (see Discussion). Mice bearing the BrgO allele were then generated, and their thymocytes were analyzed as described below.
###end p 19
###begin title 20
###xml 3 6 3 6 <sup xmlns:xlink="http://www.w3.org/1999/xlink">O/+</sup>
###xml 53 56 53 56 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/&#8722;</sup>
###xml 7 11 <span type="species:ncbi:10090|species:ncbi:10095">mice</span>
###xml 57 61 <span type="species:ncbi:10090|species:ncbi:10095">mice</span>
BrgO/+ mice recapitulate the thymocyte defects in Brg+/- mice
###end title 20
###begin p 21
###xml 48 51 48 51 <sup xmlns:xlink="http://www.w3.org/1999/xlink">O/+</sup>
###xml 72 73 72 73 <sup xmlns:xlink="http://www.w3.org/1999/xlink">O</sup>
###xml 356 357 356 357 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib8">8</xref>
###xml 359 361 359 361 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib22">22</xref>
###xml 460 461 460 461 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib8">8</xref>
###xml 463 465 463 465 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib22">22</xref>
###xml 530 532 530 532 <sup xmlns:xlink="http://www.w3.org/1999/xlink">hi</sup>
###xml 551 555 551 555 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/lo</sup>
###xml 590 598 590 598 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig2" ref-type="fig">Fig. 2 A</xref>
###xml 693 694 693 694 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 698 699 698 699 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 719 720 719 720 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 724 725 724 725 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 727 735 727 735 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig2" ref-type="fig">Fig. 2 A</xref>
###xml 869 870 869 870 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 873 874 873 874 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 876 884 876 884 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig2" ref-type="fig">Fig. 2 A</xref>
###xml 960 961 960 961 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 964 965 964 965 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 976 977 976 977 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 980 981 980 981 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 1213 1215 1213 1215 <sup xmlns:xlink="http://www.w3.org/1999/xlink">hi</sup>
###xml 1218 1219 1218 1219 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 1221 1229 1221 1229 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig2" ref-type="fig">Fig. 2 A</xref>
###xml 52 56 <span type="species:ncbi:10090|species:ncbi:10095">mice</span>
###xml 826 830 <span type="species:ncbi:10090|species:ncbi:10095">mice</span>
###xml 935 939 <span type="species:ncbi:10090|species:ncbi:10095">mice</span>
We first determined the thymic phenotypes in BrgO/+ mice bearing the BrgO allele together with the WT Brg allele. Developmental stages of thymocytes are usually defined by a CD4/CD8 expression pattern, but such a definition is invalid if the coreceptors are misregulated, as in the case of Brg deletion that derepresses CD4 while impairing CD8 expression (8, 22). We therefore used CD25/CD44, together with CD3, as maturation markers, as previously described (8, 22). In brief, total thymocytes are first resolved into mature (CD3hi) and immature (CD3-/lo) subsets based on CD3 expression (Fig. 2 A, column 1). The immature thymocytes are then resolved into two major subsets, namely DN3 (CD25+CD44-) and post-DN3 (CD25-CD44-; Fig. 2 A, column 2) before each population is analyzed for CD4/CD8 expression (columns 3-5). In WT mice, the DN3 cells are, by definition, CD4-CD8- (Fig. 2 A, row A, column 3). The post-DN3 compartment in WT mice consists of DN4 (CD4-CD8-), ISP (CD4-CD8+), and DP cells; the DN4 and ISP subsets are enriched and detectable only within the "post-DN3 blasts" population, the most immature cells in the post-DN3 pool marked by high forward scatter and a complete lack of CD3 expression (FShiCD3-; Fig. 2 A, row A, column 5).
###end p 21
###begin p 22
###xml 0 72 0 72 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Effects of Brg point mutation and Brg deletion on thymocyte development.</bold>
###xml 832 835 830 833 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Brg</italic>
###xml 835 836 833 834 <sup xmlns:xlink="http://www.w3.org/1999/xlink">O</sup>
###xml 841 844 839 842 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Brg</italic>
###xml 844 845 842 843 <sup xmlns:xlink="http://www.w3.org/1999/xlink">F</sup>
###xml 256 260 <span type="species:ncbi:10090|species:ncbi:10095">mice</span>
###xml 288 292 <span type="species:ncbi:10090|species:ncbi:10095">Mice</span>
###xml 344 348 <span type="species:ncbi:10090|species:ncbi:10095">mice</span>
###xml 909 913 <span type="species:ncbi:10090|species:ncbi:10095">mice</span>
###xml 1177 1181 <span type="species:ncbi:10090|species:ncbi:10095">mice</span>
###xml 1333 1337 <span type="species:ncbi:10090|species:ncbi:10095">mice</span>
Effects of Brg point mutation and Brg deletion on thymocyte development. (A) Thymocytes were resolved into various subsets based on CD3, CD25, and CD44 expression, and the CD4/CD8 expression profile of each subset was then determined. The genotypes of the mice are indicated (far right). Mice in rows A-C were analyzed at a different time than mice in rows D-F. The total cell number of each strain (+/-SD) is indicated inside the FACS plots in column 1. Red circles mark significantly changed populations; green borders are shown to facilitate comparisons. Note that in Brg point mutants, CD25 expression in post-DN3 cells is elevated, and therefore the post-DN3 gates are correspondingly enlarged (row E, column 2). Percentages of cells are shown. Data are representative of three independent experiments. (B) PCR analysis of the BrgO and BrgF alleles. DNA was isolated from thymocytes pooled from multiple mice to avoid sampling errors. Asterisks indicate internal controls for PCR (see Materials and methods for details). (C) Quantification of cellularity. (top) Comparison of the abundance of total, DN3, and post-DN3 thymocytes in the Brg mutants relative to those in WT mice, set as 100. (bottom) Comparison of the percentages of various components of the post-DN3 pool in the Brg mutants. Data represent the means from three mice.
###end p 22
###begin p 23
###xml 36 39 36 39 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/&#8722;</sup>
###xml 263 264 263 264 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 267 268 267 268 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 332 334 332 334 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib22">22</xref>
###xml 375 378 375 378 <sup xmlns:xlink="http://www.w3.org/1999/xlink">O/+</sup>
###xml 385 393 385 393 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig2" ref-type="fig">Fig. 2 A</xref>
###xml 451 452 451 452 <sup xmlns:xlink="http://www.w3.org/1999/xlink">O</sup>
###xml 523 526 523 526 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/&#8722;</sup>
###xml 582 585 582 585 <sup xmlns:xlink="http://www.w3.org/1999/xlink">O/+</sup>
###xml 765 767 765 767 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib22">22</xref>
###xml 40 44 <span type="species:ncbi:10090|species:ncbi:10095">mice</span>
###xml 379 383 <span type="species:ncbi:10090|species:ncbi:10095">mice</span>
###xml 527 531 <span type="species:ncbi:10090|species:ncbi:10095">mice</span>
###xml 586 590 <span type="species:ncbi:10090|species:ncbi:10095">mice</span>
###xml 613 617 <span type="species:ncbi:10090|species:ncbi:10095">mice</span>
We have previously shown that in Brg+/- mice, the only detectable phenotype is impairment in CD8 expression in early thymocytes, which is manifested as a triad of concurrent developmental defects within post-DN3 blasts: loss of ISP cells, emergence of a novel CD4+CD8- population, and reduction in CD8 expression in early DP cells (22). These defects are recapitulated in BrgO/+ mice (Fig. 2 A, row B, column 5), as expected from the fact that the BrgO allele is a null allele by default. In addition, as in the case of Brg+/- mice, there is no other obvious thymocyte defect in BrgO/+ mice. In particular, these mice contain normal numbers of cells in the DN4 compartment, reinforcing the notion that deleting one allele of Brg is not sufficient to derepress CD4 (22).
###end p 23
###begin title 24
###xml 24 27 24 27 <sup xmlns:xlink="http://www.w3.org/1999/xlink">O/+</sup>
###xml 36 39 36 39 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/&#8722;</sup>
###xml 40 44 <span type="species:ncbi:10090|species:ncbi:10095">mice</span>
Loss of DN4 cells in BrgO/+; LCK-Cre+/- mice
###end title 24
###begin p 25
###xml 118 121 118 121 <sup xmlns:xlink="http://www.w3.org/1999/xlink">O/+</sup>
###xml 181 184 181 184 <sup xmlns:xlink="http://www.w3.org/1999/xlink">O/+</sup>
###xml 189 192 189 192 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/&#8722;</sup>
###xml 304 312 280 288 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig2" ref-type="fig">Fig. 2 A</xref>
###xml 497 500 473 476 <sup xmlns:xlink="http://www.w3.org/1999/xlink">O/+</sup>
###xml 604 605 580 581 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 608 609 584 585 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 679 687 655 663 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig2" ref-type="fig">Fig. 2 A</xref>
###xml 760 763 736 739 <sup xmlns:xlink="http://www.w3.org/1999/xlink">O/+</sup>
###xml 768 771 744 747 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/&#8722;</sup>
###xml 122 126 <span type="species:ncbi:10090|species:ncbi:10095">mice</span>
###xml 193 197 <span type="species:ncbi:10090|species:ncbi:10095">mice</span>
###xml 501 505 <span type="species:ncbi:10090|species:ncbi:10095">mice</span>
###xml 772 776 <span type="species:ncbi:10090|species:ncbi:10095">mice</span>
We next examined the effects of Brg point mutation on T cell development by introducing the LCK-Cre transgene into BrgO/+ mice. There is no gross defect in T cell development in BrgO/+; Cre+/- mice, although the total thymocyte number is mildly reduced (from approximately136 to approximately98 million; Fig. 2 A, row C, column 1), largely because of a decrease in DP cells. Neither is there a significant change in the cellularity of the peripheral CD4 and CD8 cells (unpublished data). As in BrgO/+ mice, CD8 expression in early thymocytes is impaired, resulting in the loss of ISP and emergence of CD4+CD8- cells, but the CD8 expression level on DP cells seems less affected (Fig. 2 A, row C, column 5). Surprisingly, DN4 cells are completely missing in BrgO/+; Cre+/- mice (red circles). As DN4 cells are an essential intermediate in T cell development, these cells must be present but have somehow become phenotypically undetectable (see Discussion).
###end p 25
###begin p 26
###xml 38 39 38 39 <sup xmlns:xlink="http://www.w3.org/1999/xlink">O</sup>
###xml 90 93 90 93 <sup xmlns:xlink="http://www.w3.org/1999/xlink">O/+</sup>
###xml 98 101 98 101 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/&#8722;</sup>
###xml 115 116 115 116 <sup xmlns:xlink="http://www.w3.org/1999/xlink">O</sup>
###xml 262 263 262 263 <sup xmlns:xlink="http://www.w3.org/1999/xlink">O</sup>
###xml 314 322 314 322 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig2" ref-type="fig">Fig. 2 B</xref>
###xml 349 350 349 350 <sup xmlns:xlink="http://www.w3.org/1999/xlink">O</sup>
###xml 536 537 536 537 <sup xmlns:xlink="http://www.w3.org/1999/xlink">F</sup>
###xml 576 579 576 579 <sup xmlns:xlink="http://www.w3.org/1999/xlink">F/+</sup>
###xml 584 587 584 587 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/&#8722;</sup>
###xml 673 674 673 674 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib8">8</xref>
###xml 102 106 <span type="species:ncbi:10090|species:ncbi:10095">mice</span>
###xml 588 592 <span type="species:ncbi:10090|species:ncbi:10095">mice</span>
We then analyzed the status of the BrgO allele in various cell types isolated from the BrgO/+; Cre+/- mice. The BrgO allele appears to be fully converted to the Brg (K/R) allele in DP cells and in peripheral CD4 and CD8 cells, as indicated by the loss of the BrgO allele, whereas DN3 cells show little conversion (Fig. 2 B, top). The loss of the BrgO allele was accompanied by the emergence of the Brg (K/R) allele, as expected (unpublished data). This temporal-specific conversion is consistent with the progressive deletion of the BrgF allele by the LCK-Cre transgene in BrgF/+; Cre+/- mice, where deletion is marginal in DN2 and DN3 cells but complete by the DN4 stage (8).
###end p 26
###begin p 27
###xml 24 25 24 25 <sup xmlns:xlink="http://www.w3.org/1999/xlink">O</sup>
###xml 88 91 86 89 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Brg</italic>
###xml 91 94 89 92 <sup xmlns:xlink="http://www.w3.org/1999/xlink">O/+</sup>
###xml 99 102 97 100 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/&#8722;</sup>
###xml 200 203 198 201 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Brg</italic>
###xml 377 380 375 378 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Brg</italic>
###xml 380 383 378 381 <sup xmlns:xlink="http://www.w3.org/1999/xlink">O/+</sup>
###xml 103 107 <span type="species:ncbi:10090|species:ncbi:10095">mice</span>
###xml 395 399 <span type="species:ncbi:10090|species:ncbi:10095">mice</span>
We conclude that the BrgO-->Brg (K/R) conversion is induced by the LCK-Cre transgene in BrgO/+; Cre+/- mice, but there is no gross perturbation of thymocyte development, suggesting that one allele of Brg is largely sufficient to mask the effects of Brg point mutation on thymocytes. Of note, this scenario is not generally true for other cell types, because we could not breed BrgO/+; Actin-Cre mice carrying a transgene ubiquitously expressing Cre, apparently because of embryonic lethality (unpublished data).
###end p 27
###begin title 28
###xml 31 34 31 34 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Brg</italic>
###xml 34 37 34 37 <sup xmlns:xlink="http://www.w3.org/1999/xlink">F/O</sup>
###xml 46 49 46 49 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/&#8722;</sup>
###xml 54 57 54 57 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Brg</italic>
###xml 57 60 57 60 <sup xmlns:xlink="http://www.w3.org/1999/xlink">F/F</sup>
###xml 69 72 69 72 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/&#8722;</sup>
###xml 73 77 <span type="species:ncbi:10090|species:ncbi:10095">mice</span>
Phenotypic differences between BrgF/O; LCK-Cre+/- and BrgF/F; LCK-Cre+/- mice
###end title 28
###begin p 29
###xml 86 89 86 89 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Brg</italic>
###xml 89 92 89 92 <sup xmlns:xlink="http://www.w3.org/1999/xlink">F/O</sup>
###xml 101 104 101 104 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/&#8722;</sup>
###xml 140 143 140 143 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Brg</italic>
###xml 143 144 143 144 <sup xmlns:xlink="http://www.w3.org/1999/xlink">O</sup>
###xml 147 150 145 148 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Brg</italic>
###xml 175 178 173 176 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Brg</italic>
###xml 178 179 176 177 <sup xmlns:xlink="http://www.w3.org/1999/xlink">O</sup>
###xml 208 211 206 209 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Brg</italic>
###xml 211 212 209 210 <sup xmlns:xlink="http://www.w3.org/1999/xlink">F</sup>
###xml 271 274 269 272 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Brg</italic>
###xml 274 277 272 275 <sup xmlns:xlink="http://www.w3.org/1999/xlink">F/F</sup>
###xml 286 289 284 287 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/&#8722;</sup>
###xml 105 109 <span type="species:ncbi:10090|species:ncbi:10095">mice</span>
###xml 290 294 <span type="species:ncbi:10090|species:ncbi:10095">mice</span>
To fully expose the effects of Brg point mutation on T cell development, we generated BrgF/O; LCK-Cre+/- mice in which Cre not only induces BrgO-->Brg (K/R) conversion in the BrgO allele but also deletes the BrgF allele that is masking the effects of Brg point mutation. BrgF/F; LCK-Cre+/- mice were used as littermate controls.
###end p 29
###begin p 30
###xml 36 39 36 39 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Brg</italic>
###xml 39 42 39 42 <sup xmlns:xlink="http://www.w3.org/1999/xlink">F/&#8722;</sup>
###xml 51 54 51 54 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/&#8722;</sup>
###xml 72 75 72 75 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Brg</italic>
###xml 75 76 75 76 <sup xmlns:xlink="http://www.w3.org/1999/xlink">F</sup>
###xml 115 118 115 118 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Brg</italic>
###xml 132 135 132 135 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Brg</italic>
###xml 135 136 135 136 <sup xmlns:xlink="http://www.w3.org/1999/xlink">F</sup>
###xml 203 206 203 206 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Brg</italic>
###xml 283 284 283 284 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib8">8</xref>
###xml 301 304 301 304 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Brg</italic>
###xml 304 307 304 307 <sup xmlns:xlink="http://www.w3.org/1999/xlink">F/O</sup>
###xml 312 315 312 315 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/&#8722;</sup>
###xml 523 531 511 519 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig2" ref-type="fig">Fig. 2 A</xref>
###xml 565 573 553 561 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig2" ref-type="fig">Fig. 2 C</xref>
###xml 740 743 716 719 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Brg</italic>
###xml 743 746 719 722 <sup xmlns:xlink="http://www.w3.org/1999/xlink">F/O</sup>
###xml 751 754 727 730 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/&#8722;</sup>
###xml 808 811 784 787 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Brg</italic>
###xml 811 814 787 790 <sup xmlns:xlink="http://www.w3.org/1999/xlink">F/&#8722;</sup>
###xml 823 826 799 802 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/&#8722;</sup>
###xml 971 974 947 950 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Brg</italic>
###xml 974 975 950 951 <sup xmlns:xlink="http://www.w3.org/1999/xlink">O</sup>
###xml 996 999 972 975 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Brg</italic>
###xml 999 1000 975 976 <sup xmlns:xlink="http://www.w3.org/1999/xlink">F</sup>
###xml 1181 1184 1157 1160 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Brg</italic>
###xml 1184 1187 1160 1163 <sup xmlns:xlink="http://www.w3.org/1999/xlink">F/F</sup>
###xml 1192 1195 1168 1171 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/&#8722;</sup>
###xml 1281 1284 1257 1260 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Brg</italic>
###xml 1284 1285 1260 1261 <sup xmlns:xlink="http://www.w3.org/1999/xlink">F</sup>
###xml 1296 1304 1272 1280 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig2" ref-type="fig">Fig. 2 A</xref>
###xml 1334 1342 1310 1318 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig2" ref-type="fig">Fig. 2 C</xref>
###xml 1393 1396 1369 1372 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Brg</italic>
###xml 1518 1521 1494 1497 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Brg</italic>
###xml 1521 1524 1497 1500 <sup xmlns:xlink="http://www.w3.org/1999/xlink">F/F</sup>
###xml 1529 1532 1505 1508 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/&#8722;</sup>
###xml 1620 1623 1596 1599 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Brg</italic>
###xml 1623 1626 1599 1602 <sup xmlns:xlink="http://www.w3.org/1999/xlink">F/O</sup>
###xml 1631 1634 1607 1610 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/&#8722;</sup>
###xml 1641 1649 1617 1625 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig2" ref-type="fig">Fig. 2 A</xref>
###xml 1751 1754 1727 1730 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Brg</italic>
###xml 1754 1757 1730 1733 <sup xmlns:xlink="http://www.w3.org/1999/xlink">F/O</sup>
###xml 1762 1765 1738 1741 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/&#8722;</sup>
###xml 1795 1796 1771 1772 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 1799 1800 1775 1776 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 1919 1922 1895 1898 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Brg</italic>
###xml 1922 1925 1898 1901 <sup xmlns:xlink="http://www.w3.org/1999/xlink">F/F</sup>
###xml 1930 1933 1906 1909 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/&#8722;</sup>
###xml 1940 1948 1916 1924 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig2" ref-type="fig">Fig. 2 A</xref>
###xml 1978 1986 1954 1962 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig2" ref-type="fig">Fig. 2 C</xref>
###xml 2021 2022 1997 1998 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 2025 2026 2001 2002 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 2075 2078 2051 2054 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Brg</italic>
###xml 2078 2081 2054 2057 <sup xmlns:xlink="http://www.w3.org/1999/xlink">F/F</sup>
###xml 2086 2089 2062 2065 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/&#8722;</sup>
###xml 2096 2104 2072 2080 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig2" ref-type="fig">Fig. 2 A</xref>
###xml 2134 2142 2110 2118 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig2" ref-type="fig">Fig. 2 C</xref>
###xml 55 59 <span type="species:ncbi:10090|species:ncbi:10095">mice</span>
###xml 316 320 <span type="species:ncbi:10090|species:ncbi:10095">mice</span>
###xml 755 759 <span type="species:ncbi:10090|species:ncbi:10095">mice</span>
###xml 827 831 <span type="species:ncbi:10090|species:ncbi:10095">mice</span>
###xml 1196 1200 <span type="species:ncbi:10090|species:ncbi:10095">mice</span>
###xml 1533 1537 <span type="species:ncbi:10090|species:ncbi:10095">mice</span>
###xml 1635 1639 <span type="species:ncbi:10090|species:ncbi:10095">mice</span>
###xml 1766 1770 <span type="species:ncbi:10090|species:ncbi:10095">mice</span>
###xml 1934 1938 <span type="species:ncbi:10090|species:ncbi:10095">mice</span>
###xml 2090 2094 <span type="species:ncbi:10090|species:ncbi:10095">mice</span>
###xml 2294 2298 <span type="species:ncbi:10090|species:ncbi:10095">mice</span>
We have previously reported that in BrgF/-; LCK-Cre+/- mice bearing the BrgF allele together with the constitutive Brg null allele, BrgF is hardly deleted in DN3 but completely deleted in DN4 cells, and Brg-deleted DN4 cells rapidly die by apoptosis before they can further develop (8). Similarly, in BrgF/O; Cre+/- mice, thymocyte numbers are severely reduced (approximately13-fold) because of a loss of post-DN3 cells, and there are few CD4/CD8 SP cells in the thymus or periphery, whereas DN3 cellularity is unaffected (Fig. 2 A, row E, columns 1, 2, and 6; and Fig. 2 C, top). This indicates that Brg ATPase is important for thymocyte development. However, a small number of post-DN3 cells (approximately5 million) manage to develop in BrgF/O; Cre+/- mice, whereas post-DN3 cells are virtually absent in BrgF/-; LCK-Cre+/- mice, suggesting that Brg (K/R) retains the residual ability to support post-DN3 production. In addition, the presence of two loxP sites in the BrgO allele might impair BrgF deletion via competition for the Cre recombinase, thus contributing to the generation of the post-DN3 cells. Interestingly, a similar number of post-DN3 cells is also generated in BrgF/F; Cre+/- mice, which presumably also represents a "leaky" phenotype resulting from incomplete BrgF deletion (Fig. 2 A, row F, columns 1 and 2; and Fig. 2 C, top). Importantly, the post-DN3 cells in the two Brg mutant strains differ in two ways, and the difference apparently cannot be ascribed to the leakiness in the phenotype in BrgF/F; Cre+/- mice. First, these cells aberrantly express low to intermediate levels of CD25 only in BrgF/O; Cre+/- mice (Fig. 2 A, rows D-F, column 2). The second difference lies in the composition of post-DN3 cells. Specifically, BrgF/O; Cre+/- mice harbor a conspicuous CD4+CD8- population that constitutes, on average, 38% of the total post-DN3 pool, whereas this population makes up only 14% in BrgF/F; Cre+/- mice (Fig. 2 A, rows E and F, column 4; and Fig. 2 C, bottom). On the other hand, a CD4-CD8+ subset, analogous to ISP cells, is seen only in BrgF/F; Cre+/- mice (Fig. 2 A, rows E and F, column 4; and Fig. 2 C, bottom). It is not clear whether this subset is bona fide ISP cells, because the majority of this subset has small cell size, whereas ISP cells in WT mice are large blasts.
###end p 30
###begin p 31
###xml 72 75 72 75 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Brg</italic>
###xml 101 104 101 104 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Brg</italic>
###xml 104 107 104 107 <sup xmlns:xlink="http://www.w3.org/1999/xlink">F/O</sup>
###xml 112 115 112 115 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/&#8722;</sup>
###xml 122 125 122 125 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Brg</italic>
###xml 125 126 125 126 <sup xmlns:xlink="http://www.w3.org/1999/xlink">O</sup>
###xml 129 132 127 130 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Brg</italic>
###xml 154 157 152 155 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Brg</italic>
###xml 157 158 155 156 <sup xmlns:xlink="http://www.w3.org/1999/xlink">F</sup>
###xml 243 244 241 242 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 247 248 245 246 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 263 271 261 269 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig2" ref-type="fig">Fig. 2 B</xref>
###xml 307 310 305 308 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Brg</italic>
###xml 310 313 308 311 <sup xmlns:xlink="http://www.w3.org/1999/xlink">F/F</sup>
###xml 318 321 316 319 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/&#8722;</sup>
###xml 328 331 326 329 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Brg</italic>
###xml 331 332 329 330 <sup xmlns:xlink="http://www.w3.org/1999/xlink">F</sup>
###xml 418 419 416 417 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 422 423 420 421 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 428 429 426 427 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 432 433 430 431 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 450 458 448 456 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig2" ref-type="fig">Fig. 2 B</xref>
###xml 520 523 518 521 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Brg</italic>
###xml 523 524 521 522 <sup xmlns:xlink="http://www.w3.org/1999/xlink">F</sup>
###xml 116 120 <span type="species:ncbi:10090|species:ncbi:10095">mice</span>
###xml 322 326 <span type="species:ncbi:10090|species:ncbi:10095">mice</span>
###xml 656 660 <span type="species:ncbi:10090|species:ncbi:10095">mice</span>
We then isolated major thymocyte subsets and analyzed the status of the Brg alleles. As expected, in BrgF/O; Cre+/- mice, BrgO-->Brg (K/R) conversion and BrgF deletion are each minimal/undetectable in DN3 cells but appear to be complete in CD4+CD8- and DP cells (Fig. 2 B, middle, lanes 2-4). Similarly, in BrgF/F; Cre+/- mice, BrgF deletion is minimal/undetectable in DN3 and virtually complete in post-DN3 (i.e., CD4+CD8-, CD4-CD8+, and DP) cells (Fig. 2 B, bottom, lanes 2-5); the presence of residual amounts of the BrgF allele in post-DN3 cells, revealed by faint PCR bands in lanes 3-5, is consistent with the aforementioned leaky phenotype in these mice. We conclude that Brg point mutation produces similar but not identical defects as Brg deletion.
###end p 31
###begin title 32
Phenotypic differences in Bcl-xL-rescued thymocytes
###end title 32
###begin p 33
###xml 330 332 330 332 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib23">23</xref>
###xml 372 375 372 375 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Brg</italic>
###xml 375 378 375 378 <sup xmlns:xlink="http://www.w3.org/1999/xlink">F/&#8722;</sup>
###xml 383 386 383 386 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/&#8722;</sup>
###xml 481 482 481 482 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib8">8</xref>
###xml 804 807 802 805 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Brg</italic>
###xml 807 810 805 808 <sup xmlns:xlink="http://www.w3.org/1999/xlink">F/&#8722;</sup>
###xml 815 818 813 816 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/&#8722;</sup>
###xml 826 829 824 827 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/+</sup>
###xml 903 906 901 904 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Brg</italic>
###xml 906 909 904 907 <sup xmlns:xlink="http://www.w3.org/1999/xlink">F/&#8722;</sup>
###xml 914 917 912 915 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/&#8722;</sup>
###xml 1262 1263 1260 1261 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib8">8</xref>
###xml 387 391 <span type="species:ncbi:10090|species:ncbi:10095">mice</span>
###xml 830 834 <span type="species:ncbi:10090|species:ncbi:10095">mice</span>
###xml 918 922 <span type="species:ncbi:10090|species:ncbi:10095">mice</span>
Although the post-DN3 cells in the two Brg mutant strains show phenotypic differences, these cells are scarce and are undergoing apoptosis, thus confounding interpretations and hampering mechanistic studies. To circumvent these problems, we introduced a transgene expressing Bcl-xL under the control of the LCK-proximal promoter (23). This transgene, when introduced into BrgF/-; Cre+/- mice, was able to rescue Brg-deleted DN4 cells from apoptosis, leading to their accumulation (8). The DN4 cells do not accumulate because they hyperproliferate: these cells are in fact completely cell-cycle arrested, and most of them are atrophic. The accumulation instead results from a blockade in DN4-->DP differentiation, based on the fact that DP cells are virtually absent even though DN4 cells are abundant in BrgF/-; Cre+/-; Bcl-xL+/+ mice. In addition, Brg-deleted DN3 cells, which are hardly detectable in BrgF/-; Cre+/- mice, are also rescued from death and subsequently accumulate. The accumulation similarly results from a blockade in differentiation (into DN4 cells) rather than hyperproliferation, because the rescued DN3 cells are cell-cycle arrested. Furthermore, a subset of Brg-deleted, Bcl-xL-rescued DN3 and DN4 cells undergo premature CD4 derepression (8).
###end p 33
###begin p 34
###xml 17 20 17 20 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Brg</italic>
###xml 20 23 20 23 <sup xmlns:xlink="http://www.w3.org/1999/xlink">F/F</sup>
###xml 28 31 28 31 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/&#8722;</sup>
###xml 39 42 39 42 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/+</sup>
###xml 66 69 66 69 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Brg</italic>
###xml 99 102 95 98 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Brg</italic>
###xml 102 105 98 101 <sup xmlns:xlink="http://www.w3.org/1999/xlink">F/&#8722;</sup>
###xml 110 113 106 109 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/&#8722;</sup>
###xml 121 124 117 120 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/+</sup>
###xml 276 279 272 275 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Brg</italic>
###xml 279 282 275 278 <sup xmlns:xlink="http://www.w3.org/1999/xlink">F/F</sup>
###xml 287 290 283 286 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/&#8722;</sup>
###xml 313 316 309 312 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Brg</italic>
###xml 329 337 321 329 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig3" ref-type="fig">Fig. 3 A</xref>
###xml 365 368 357 360 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Brg</italic>
###xml 368 371 360 363 <sup xmlns:xlink="http://www.w3.org/1999/xlink">F/&#8722;</sup>
###xml 376 379 368 371 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/&#8722;</sup>
###xml 387 390 379 382 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/+</sup>
###xml 455 456 447 448 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 468 469 460 461 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 481 482 473 474 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib8">8</xref>
###xml 498 499 490 491 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 502 503 494 495 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 511 512 503 504 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 515 516 507 508 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 674 682 666 674 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig3" ref-type="fig">Fig. 3 A</xref>
###xml 733 736 725 728 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Brg</italic>
###xml 906 914 892 900 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig3" ref-type="fig">Fig. 3 A</xref>
###xml 962 963 948 949 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 966 967 952 953 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 991 994 977 980 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Brg</italic>
###xml 994 997 980 983 <sup xmlns:xlink="http://www.w3.org/1999/xlink">F/F</sup>
###xml 1002 1005 988 991 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/&#8722;</sup>
###xml 1027 1030 1013 1016 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Brg</italic>
###xml 1043 1051 1025 1033 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig3" ref-type="fig">Fig. 3 A</xref>
###xml 1187 1195 1169 1177 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig3" ref-type="fig">Fig. 3 A</xref>
###xml 1267 1275 1249 1257 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig3" ref-type="fig">Fig. 3 B</xref>
###xml 43 47 <span type="species:ncbi:10090|species:ncbi:10095">mice</span>
###xml 125 129 <span type="species:ncbi:10090|species:ncbi:10095">mice</span>
###xml 291 295 <span type="species:ncbi:10090|species:ncbi:10095">mice</span>
###xml 323 327 <span type="species:ncbi:10090|species:ncbi:10095">mice</span>
###xml 391 395 <span type="species:ncbi:10090|species:ncbi:10095">mice</span>
###xml 743 747 <span type="species:ncbi:10090|species:ncbi:10095">mice</span>
###xml 845 849 <span type="species:ncbi:10090|species:ncbi:10095">mice</span>
###xml 1006 1010 <span type="species:ncbi:10090|species:ncbi:10095">mice</span>
###xml 1037 1041 <span type="species:ncbi:10090|species:ncbi:10095">mice</span>
The phenotype of BrgF/F; Cre+/-; Bcl-xL+/+ mice (hereafter called Brg Delta) is similar to that of BrgF/-; Cre+/-; Bcl-xL+/+ mice, although the former contains threefold more thymocytes. Specifically, total thymocyte cellularity is increased almost 10-fold, from 9 million in BrgF/F; Cre+/- mice to 83 million in Brg Delta mice (Fig. 3 A, row C). As in the case of BrgF/-; Cre+/-; Bcl-xL+/+ mice, this increase results largely from the accumulation of CD4- DN4 and CD4+ DN4 cells (8), i.e., the CD4-CD8- and CD4+CD8- populations in the post-DN3 pool; these cells are mostly atrophic and, thus, detectable not only within post-DN3 blasts but also in the total post-DN3 pool (Fig. 3 A, row C, columns 3 and 4). DP cells are present in Brg Delta mice, but their cellularity relative to DN4 cells is dramatically reduced as compared with that in WT mice, indicating a severe defect in the DN4-->DP transition (Fig. 3 A, row A vs. C, column 3). Interestingly, the CD4-CD8+ subset, conspicuous in BrgF/F; Cre+/- mice, is absent from Brg Delta mice (Fig. 3 A, row C, column 3). Brg-deleted DN3 cells are similarly rescued, and they accumulate and undergo partial CD4 derepression as DN4 cells (Fig. 3 A, row C, column 2), and both DN3 and DN4 cells are cell-cycle arrested (Fig. 3 B).
###end p 34
###begin p 35
###xml 0 49 0 49 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Phenotypic analysis of Bcl-xL&#8211;rescued thymocytes.</bold>
###xml 149 157 149 157 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig2" ref-type="fig">Fig. 2 A</xref>
###xml 392 393 390 391 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 437 445 435 443 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig4" ref-type="fig">Fig. 4 A</xref>
###xml 450 453 448 451 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Brg</italic>
###xml 861 862 859 860 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 1291 1294 1289 1292 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Brg</italic>
###xml 1294 1295 1292 1293 <sup xmlns:xlink="http://www.w3.org/1999/xlink">O</sup>
###xml 1311 1314 1309 1312 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Brg</italic>
###xml 1314 1315 1312 1313 <sup xmlns:xlink="http://www.w3.org/1999/xlink">F</sup>
###xml 1366 1370 1364 1368 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Brg*</italic>
###xml 1375 1384 1373 1378 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Brg &#916;</italic>
###xml 1392 1395 1386 1389 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Brg</italic>
###xml 1395 1398 1389 1392 <sup xmlns:xlink="http://www.w3.org/1999/xlink">F/O</sup>
###xml 1403 1406 1397 1400 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/&#8722;</sup>
###xml 1414 1417 1408 1411 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/+</sup>
###xml 1422 1425 1416 1419 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Brg</italic>
###xml 1425 1428 1419 1422 <sup xmlns:xlink="http://www.w3.org/1999/xlink">F/F</sup>
###xml 1433 1436 1427 1430 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/&#8722;</sup>
###xml 1444 1447 1438 1441 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/+</sup>
###xml 1509 1517 1503 1511 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig2" ref-type="fig">Fig. 2 B</xref>
###xml 455 459 <span type="species:ncbi:10090|species:ncbi:10095">mice</span>
###xml 752 756 <span type="species:ncbi:10090|species:ncbi:10095">mice</span>
###xml 883 887 <span type="species:ncbi:10090|species:ncbi:10095">mice</span>
###xml 1267 1271 <span type="species:ncbi:10090|species:ncbi:10095">mice</span>
###xml 1448 1452 <span type="species:ncbi:10090|species:ncbi:10095">mice</span>
###xml 1581 1585 <span type="species:ncbi:10090|species:ncbi:10095">mice</span>
Phenotypic analysis of Bcl-xL-rescued thymocytes. (A) CD4/CD8 expression pattern of various thymocyte subsets. Cells were stained and analyzed as in Fig. 2 A. The total cell number (+/-SD) for each strain is indicated within the plots in column 1. Red circles mark differences in CD4 expression in the indicated subset between two mutants. The blue-shaded region in column 4 indicates the CD8- cells whose CD4 expression was analyzed in Fig. 4 A. In Brg* mice, CD25 is elevated in post-DN3 cells, and the post-DN3 gate is enlarged accordingly (row B, column 1). Percentages of cells are shown. Data are representative of three independent experiments. (B) Histograms comparing BrdU incorporation efficiencies of DN3 and 4 cells. BrdU was injected into mice and thymocytes were analyzed 15 min later. The numbers within the plots indicate the percentages of BrdU+ cells. At least two mice in each group were analyzed. (C) CD25 expression in immature T cells in A was analyzed by histograms. The vertical line within the plot marks the boundary between DN3 and post-DN3 cells, with the DN3 cells located to the right of the line. (D) Bar graph comparing the percentages of various components of the post-DN3 pool in the Brg mutants. Data represent the means from three mice. (E-G) Analysis of BrgO conversion and BrgF deletion at DNA (E and F) and protein (G) levels. Brg* and Brg Delta denote BrgF/O; Cre+/-; Bcl-xL+/+ and BrgF/F; Cre+/-; Bcl-xL+/+ mice, respectively. The PCR assays are identical to those in Fig. 2 B. Cell subsets were sorted from thymocytes pooled from multiple mice to avoid sampling errors.
###end p 35
###begin p 36
###xml 21 24 21 24 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Brg</italic>
###xml 24 27 24 27 <sup xmlns:xlink="http://www.w3.org/1999/xlink">F/O</sup>
###xml 32 35 32 35 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/&#8722;</sup>
###xml 43 46 43 46 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/+</sup>
###xml 65 68 65 68 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Brg</italic>
###xml 98 101 98 101 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Brg</italic>
###xml 221 224 205 208 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Brg</italic>
###xml 224 227 208 211 <sup xmlns:xlink="http://www.w3.org/1999/xlink">F/O</sup>
###xml 232 235 216 219 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/&#8722;</sup>
###xml 292 300 276 284 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig3" ref-type="fig">Fig. 3 A</xref>
###xml 492 500 476 484 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig3" ref-type="fig">Fig. 3 B</xref>
###xml 704 707 688 691 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Brg</italic>
###xml 721 724 705 708 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Brg</italic>
###xml 724 727 708 711 <sup xmlns:xlink="http://www.w3.org/1999/xlink">F/O</sup>
###xml 732 735 716 719 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/&#8722;</sup>
###xml 800 808 784 792 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig3" ref-type="fig">Fig. 3 A</xref>
###xml 824 832 808 816 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig3" ref-type="fig">Fig. 3 C</xref>
###xml 873 876 857 860 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Brg</italic>
###xml 943 944 923 924 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 999 1002 979 982 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Brg</italic>
###xml 1024 1027 1000 1003 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Brg</italic>
###xml 1052 1053 1028 1029 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 1081 1084 1057 1060 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Brg</italic>
###xml 1102 1105 1074 1077 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Brg</italic>
###xml 1113 1121 1085 1093 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig3" ref-type="fig">Fig. 3 D</xref>
###xml 1133 1134 1105 1106 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 1160 1163 1132 1135 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Brg</italic>
###xml 1186 1189 1154 1157 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Brg</italic>
###xml 1233 1234 1201 1202 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 1358 1361 1326 1329 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Brg</italic>
###xml 1431 1434 1395 1398 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Brg</italic>
###xml 1440 1443 1404 1407 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Brg</italic>
###xml 1443 1446 1407 1410 <sup xmlns:xlink="http://www.w3.org/1999/xlink">F/&#8722;</sup>
###xml 1451 1454 1415 1418 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/&#8722;</sup>
###xml 1462 1465 1426 1429 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/+</sup>
###xml 1514 1517 1478 1481 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Brg</italic>
###xml 1517 1520 1481 1484 <sup xmlns:xlink="http://www.w3.org/1999/xlink">F/O</sup>
###xml 1525 1528 1489 1492 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/&#8722;</sup>
###xml 1533 1536 1497 1500 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Brg</italic>
###xml 1536 1539 1500 1503 <sup xmlns:xlink="http://www.w3.org/1999/xlink">F/F</sup>
###xml 1544 1547 1508 1511 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/&#8722;</sup>
###xml 1554 1560 1518 1524 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig2" ref-type="fig">Fig. 2</xref>
###xml 71 75 <span type="species:ncbi:10090|species:ncbi:10095">mice</span>
###xml 108 112 <span type="species:ncbi:10090|species:ncbi:10095">mice</span>
###xml 236 240 <span type="species:ncbi:10090|species:ncbi:10095">mice</span>
###xml 709 713 <span type="species:ncbi:10090|species:ncbi:10095">mice</span>
###xml 736 740 <span type="species:ncbi:10090|species:ncbi:10095">mice</span>
###xml 883 887 <span type="species:ncbi:10090|species:ncbi:10095">mice</span>
###xml 1029 1033 <span type="species:ncbi:10090|species:ncbi:10095">mice</span>
###xml 1107 1111 <span type="species:ncbi:10090|species:ncbi:10095">mice</span>
###xml 1191 1195 <span type="species:ncbi:10090|species:ncbi:10095">mice</span>
###xml 1368 1372 <span type="species:ncbi:10090|species:ncbi:10095">mice</span>
###xml 1466 1470 <span type="species:ncbi:10090|species:ncbi:10095">mice</span>
###xml 1548 1552 <span type="species:ncbi:10090|species:ncbi:10095">mice</span>
The phenotype of the BrgF/O; Cre+/-; Bcl-xL+/+ (hereafter called Brg*) mice is similar to that of Brg Delta mice in four ways: total thymocyte cellularity is significantly increased (approximately8-fold) as compared with BrgF/O; Cre+/- mice, largely because of an increase in post-DN3 cells (Fig. 3 A, column 1); DP cellularity relative to DN4 cells is much reduced (column 3); DN3 cells also accumulate and partially derepress CD4 (column 2); and finally, rescued cells are growth arrested (Fig. 3 B). Thus, Brg point mutation impairs thymocyte survival, proliferation, and developmental transition, as does the Brg deletion. However, there are two differences between the Brg mutant strains. First, in Brg* mice, as in BrgF/O; Cre+/- mice, CD25 expression is aberrantly elevated in post-DN3 cells (Fig. 3 A, column 1; and Fig. 3 C), whereas this aberrance is not seen in Brg Delta mice. Second, the composition of post-DN3 cells differs: CD4-DN4 cells constitute 25% of the total post-DN3 pool in Brg Delta but only 9% in Brg* mice cells, whereas CD4+DN4 cells constitute 39% in Brg Delta but 52% in Brg* mice (Fig. 3 D). Thus, CD4-DN4 cells are enriched in Brg Delta but depleted in Brg* mice, whereas the opposite is seen for CD4+DN4 cells. The two differences between the Brg mutant strains cannot be ascribed to potential leakiness in the phenotype of Brg Delta mice, because the same differences are observed when comparing Brg* and BrgF/-; Cre+/-; Bcl-xL+/+ mice. These differences seem to have emerged in BrgF/O; Cre+/- and BrgF/F; Cre+/- mice (Fig. 2), but the situation there is complicated by cell death.
###end p 36
###begin p 37
###xml 37 40 37 40 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Brg</italic>
###xml 79 82 79 82 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Brg</italic>
###xml 101 104 97 100 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Brg</italic>
###xml 104 107 100 103 <sup xmlns:xlink="http://www.w3.org/1999/xlink">F/&#8722;</sup>
###xml 112 115 108 111 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/&#8722;</sup>
###xml 123 126 119 122 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/+</sup>
###xml 133 134 129 130 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib8">8</xref>
###xml 137 140 133 136 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Brg</italic>
###xml 140 141 136 137 <sup xmlns:xlink="http://www.w3.org/1999/xlink">F</sup>
###xml 204 212 200 208 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig3" ref-type="fig">Fig. 3 F</xref>
###xml 218 226 214 222 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig3" ref-type="fig">Fig. 3 G</xref>
###xml 251 254 247 250 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Brg</italic>
###xml 268 271 264 267 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Brg</italic>
###xml 271 272 267 268 <sup xmlns:xlink="http://www.w3.org/1999/xlink">F</sup>
###xml 288 291 284 287 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Brg</italic>
###xml 291 292 287 288 <sup xmlns:xlink="http://www.w3.org/1999/xlink">O</sup>
###xml 367 375 363 371 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig3" ref-type="fig">Fig. 3 E</xref>
###xml 381 389 377 385 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig3" ref-type="fig">Fig. 3 G</xref>
###xml 89 93 <span type="species:ncbi:10090|species:ncbi:10095">mice</span>
###xml 127 131 <span type="species:ncbi:10090|species:ncbi:10095">mice</span>
We then determined the status of the Brg alleles in DN3 and post-DN3 cells. In Brg Delta mice, as in BrgF/-; Cre+/-; Bcl-xL+/+ mice (8), BrgF is almost completely deleted and Brg protein is undetectable (Fig. 3 F; and Fig. 3 G, lanes 5-7), whereas in Brg* thymocytes, BrgF is deleted and BrgO is converted, concomitantly with the expression of the Brg (K/R) protein (Fig. 3 E; and Fig. 3 G, lanes 3 and 4).
###end p 37
###begin p 38
###xml 9 10 9 10 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 14 15 14 15 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 26 29 26 29 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Brg</italic>
###xml 40 43 36 39 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Brg</italic>
###xml 569 570 565 566 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 45 49 <span type="species:ncbi:10090|species:ncbi:10095">mice</span>
DN2 (CD25+CD44+) cells in Brg Delta and Brg* mice also accumulate and undergo partial CD4 derepression, but the extent of accumulation and CD4 derepression are rather variable in both strains (unpublished data), presumably because of inefficient and variable Cre-mediated deletion at this early stage. We conclude that Brg point mutation recapitulates the defects in cell survival, proliferation, and developmental transitions seen in Brg-deleted thymocytes, but a major difference between the two mutants lies in the unique ability of Brg point mutation to deplete CD4- DN4 cells, suggesting that Brg point mutation and deletion differentially affect CD4 transcription.
###end p 38
###begin title 39
###xml 42 45 42 45 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CD4</italic>
Brg deletion decreases the probability of CD4 transcription in DN4 cells
###end title 39
###begin p 40
###xml 0 3 0 3 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CD4</italic>
###xml 35 38 35 38 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CD4</italic>
###xml 193 194 193 194 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib1">1</xref>
###xml 196 198 196 198 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib24">24</xref>
###xml 336 339 336 339 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CD4</italic>
###xml 368 371 368 371 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CD4</italic>
###xml 399 402 399 402 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CD4</italic>
###xml 474 476 474 476 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib25">25</xref>
###xml 477 479 477 479 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib27">27</xref>
###xml 489 490 489 490 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 533 536 533 536 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Brg</italic>
###xml 536 539 536 539 <sup xmlns:xlink="http://www.w3.org/1999/xlink">F/&#8722;</sup>
###xml 544 547 544 547 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/&#8722;</sup>
###xml 555 558 555 558 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/+</sup>
###xml 658 659 646 647 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 729 732 717 720 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CD4</italic>
###xml 807 808 795 796 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib8">8</xref>
###xml 920 921 908 909 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 1007 1008 995 996 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 559 563 <span type="species:ncbi:10090|species:ncbi:10095">mice</span>
CD4 transcription is driven by the CD4 promoter and enhancer, together with a locus control region (LCR) necessary for suppressing the position-effect variegation in certain transgenic models (1, 24). Overall, these positive regulatory elements are constitutively active; the stage-specific fluctuation in CD4 expression depends on the CD4 silencer that overrides the CD4 enhancer/promoter, because CD4 silencer deletion leads to ectopic CD4 expression in DN and CD8 cells (25-27). The CD4-DN4 cells have been previously observed in BrgF/-; Cre+/-; Bcl-xL+/+ mice, constituting approximately37% of the post-DN3 population, and we have postulated that the CD4-DN4 cells arise because Brg deletion cannot completely inactivate the CD4 silencer, thus leading to CD4 derepression only in a subset of DN4 cells (8). Paradoxically, Brg point mutation, presumably less effective in silencer inactivation, is able to deplete CD4-DN4 cells, which prompted us to revisit the mechanism underlying the generation of CD4-DN4 cells.
###end p 40
###begin p 41
###xml 53 56 41 44 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Brg</italic>
###xml 82 83 70 71 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 86 87 74 75 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 110 111 98 99 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 179 180 167 168 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 183 184 171 172 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 206 207 194 195 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 220 223 208 211 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Brg</italic>
###xml 349 357 333 341 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig3" ref-type="fig">Fig. 3 A</xref>
###xml 424 432 408 416 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig3" ref-type="fig">Fig. 3 A</xref>
###xml 548 549 532 533 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 752 753 736 737 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 763 771 747 755 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig3" ref-type="fig">Fig. 3 A</xref>
###xml 961 962 945 946 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 977 980 961 964 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Brg</italic>
###xml 992 995 976 979 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Brg</italic>
###xml 1122 1125 1102 1105 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Brg</italic>
###xml 1125 1128 1105 1108 <sup xmlns:xlink="http://www.w3.org/1999/xlink">F/F</sup>
###xml 1136 1144 1116 1124 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig4" ref-type="fig">Fig. 4 A</xref>
###xml 1243 1244 1223 1224 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 1289 1292 1269 1272 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CD4</italic>
###xml 1357 1359 1337 1339 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib28">28</xref>
###xml 1461 1464 1441 1444 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CD4</italic>
###xml 1517 1520 1497 1500 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CD4</italic>
###xml 1578 1579 1558 1559 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 1646 1649 1626 1629 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CD4</italic>
###xml 1751 1754 1731 1734 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CD4</italic>
###xml 1940 1943 1920 1923 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CD4</italic>
###xml 1973 1981 1953 1961 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig4" ref-type="fig">Fig. 4 A</xref>
###xml 58 62 <span type="species:ncbi:10090|species:ncbi:10095">mice</span>
###xml 230 234 <span type="species:ncbi:10090|species:ncbi:10095">mice</span>
###xml 982 986 <span type="species:ncbi:10090|species:ncbi:10095">mice</span>
###xml 1002 1006 <span type="species:ncbi:10090|species:ncbi:10095">mice</span>
###xml 1130 1134 <span type="species:ncbi:10090|species:ncbi:10095">mice</span>
We noticed that although approximately8% of cells in Brg* mice fall within the CD4-CD8- compartment, these CD4-DN4 cells appear to express low levels of CD4 and blend into the CD4+CD8- pool, whereas the CD4-DN4 cells in Brg Delta mice appear to truly lack CD4 expression, and in many cases, form a discrete population that can be readily discerned (Fig. 3 A, column 3, red circles). This trend is upheld in post-DN3 blasts (Fig. 3 A, column 4). The data suggest that Brg point mutation uniformly derepresses CD4 in DN4 cells and turns them into CD4+DN4 cells, whereas Brg deletion leads to variegated CD4 derepression, with only a subset of DN4 cells expressing CD4. To explore this possibility, we used histograms to quantify CD4 expression in the CD8- cells in Fig. 3 A, i.e., the blue-shaded population in post-DN3 blasts and the corresponding cells in the total post-DN3 pool. In both post-DN3 blasts and the total post-DN3 pool, there is only a single, CD4+ population in Brg* mice, but Brg Delta mice harbor a second population whose CD4 expression level is, surprisingly, even lower than that on DN4 cells from WT (BrgF/F) mice (Fig. 4 A, left). WT DN4 cells are known to marginally express CD4; although DN4 cells are by definition CD4-, these cells have actually begun to turn on CD4 transcription and express some CD4 protein on the cell surface (28). Presumably, a developmentally regulated, temporal-specific mechanism has partially inactivated the CD4 silencer in DN4 cells, thus triggering the onset of CD4 transcription. The complete lack of CD4 expression on CD4-DN4 cells therefore suggests that Brg deletion blocks the onset of CD4 transcription in a subset of DN4 cells, thus revealing a positive, ATPase-independent role of Brg in CD4 transcription. Interestingly, in contrast to DN4 cells, the CD4 expression pattern on DN3 cells is indistinguishable between the two Brg mutants, suggesting that Brg is dispensable for CD4 transcription at this stage (Fig. 4 A, right).
###end p 41
###begin p 42
###xml 0 49 0 49 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Brg promotes uniform CD4 expression in DN4 cells.</bold>
###xml 94 95 94 95 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 191 199 191 199 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig3" ref-type="fig">Fig. 3 A</xref>
###xml 208 209 208 209 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 290 298 290 298 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig3" ref-type="fig">Fig. 3 A</xref>
###xml 314 317 314 317 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CD4</italic>
###xml 635 638 635 638 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Brg</italic>
###xml 638 641 638 641 <sup xmlns:xlink="http://www.w3.org/1999/xlink">F/F</sup>
###xml 713 716 713 716 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CD4</italic>
###xml 756 759 756 759 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Brg</italic>
###xml 775 776 771 772 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 1088 1091 1084 1087 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CD4</italic>
###xml 1539 1542 1535 1538 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 1615 1618 1607 1610 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 1777 1780 1769 1772 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CD4</italic>
###xml 2106 2109 2098 2101 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CD4</italic>
###xml 2277 2279 2269 2271 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib38">38</xref>
###xml 766 770 <span type="species:ncbi:10090|species:ncbi:10095">mice</span>
###xml 1214 1220 <span type="species:ncbi:9986">rabbit</span>
###xml 1543 1547 <span type="species:ncbi:10090|species:ncbi:10095">mice</span>
###xml 1619 1623 <span type="species:ncbi:10090|species:ncbi:10095">mice</span>
Brg promotes uniform CD4 expression in DN4 cells. (A) Surface CD4 expression levels on the CD8- cells in post-DN3 pool (left) and on DN3 cells (right). The data are derived from the plots in Fig. 3 A. The CD8- cells within the post-DN3 blast (left) are located in the blue-shaded region in Fig. 3 A, column 4. (B) CD4 mRNA levels in various subsets of thymocytes analyzed by semiquantitative (top) and quantitative (bottom) RT-PCR in two independent experiments. The quantitative RT-PCR was done in triplicates, the values were averaged and normalized to that of actin mRNA, and the normalized values were plotted relative to those in BrgF/F DP cells, with the latter set as 100. UD, undetectable. (C) Effects of CD4 silencer deletion on CD4 expression in Brg Delta mice. CD8- cells from blastic and total post-DN3 cells were analyzed for CD4 expression (left), as were DN3 cells (right). Vertical lines are shown to facilitate the comparison of fluorescent intensities. Data are representative of two independent experiments. (D) Chromatin immunoprecipitation analysis of Brg binding to CD4 regulatory elements. A 5-million-cell equivalent of chromatin was added to each immunoprecipitation reaction using either rabbit serum (IgG) or an anti-Brg antibody (Brg), and 40% of precipitated DNA was analyzed by semiquantitative PCR. At least two independent sources of cells were used for chromatin preparation. Asterisks indicate an amplicon from the GAPDH gene. The sizes of the amplicons (bp) are indicated (left). DN, thymocytes from Rag2-/- mice, consisting mostly of DN3 cells; DP, total thymocytes from TCRalpha-/- mice; DN4, thymocytes at the DN stages from Brg mutants, 90% of which were DN4 cells (see Materials and methods). (E) Restriction enzyme accessibility of the CD4 enhancer and LCR. Cells were partially digested with Dde I or BseR1 (red arrows), followed by DNA isolation and complete digestion with a second enzyme (Bam H1 or Alu1) that generated normalization controls. The cleaved ends were detected by ligation-mediated PCR. The cells types used were the same as those in D. Note that CD4 enhancer is equally accessible in DN and DP cells (but less so in B cells), consistent with the fact that the enhancer is poised for activation in DN cells (reference 38). The restriction enzyme cleavage sites are depicted at the bottom, where the numbers refer to the nucleotide positions of the sites. The sizes of the PCR amplicons are indicated at the left of the gels. Data are representative of at least three independent experiments.
###end p 42
###begin p 43
###xml 51 54 51 54 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CD4</italic>
###xml 75 76 75 76 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 134 142 134 142 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig4" ref-type="fig">Fig. 4 B</xref>
###xml 170 173 170 173 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Brg</italic>
###xml 173 176 173 176 <sup xmlns:xlink="http://www.w3.org/1999/xlink">F/F</sup>
###xml 184 187 184 187 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CD4</italic>
###xml 338 341 338 341 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CD4</italic>
###xml 376 377 376 377 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 392 395 392 395 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Brg</italic>
###xml 443 446 439 442 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CD4</italic>
###xml 469 470 465 466 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 489 490 485 486 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 504 507 500 503 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Brg</italic>
###xml 576 579 568 571 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CD4</italic>
###xml 631 639 623 631 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig4" ref-type="fig">Fig. 4 B</xref>
###xml 178 182 <span type="species:ncbi:10090|species:ncbi:10095">mice</span>
###xml 402 406 <span type="species:ncbi:10090|species:ncbi:10095">mice</span>
###xml 514 518 <span type="species:ncbi:10090|species:ncbi:10095">mice</span>
To confirm that Brg deletion prevents the onset of CD4 transcription in CD4-DN4 cells, we performed semiquantitative RT-PCR analysis (Fig. 4 B, top). As expected, in WT (BrgF/F) mice, CD4 mRNA is undetectable in DN3 cells but becomes detectable in DN4 cells, although the expression level is lower than DP cells (lanes 1-3). Importantly, CD4 mRNA is indeed undetectable in CD4-DN4 cells from Brg Delta mice (lane 7). As controls, we show that CD4 mRNA is present in CD4+ DN3/4 (but not CD4-DN3) cells in Brg Delta mice (lanes 4-6). Quantitative RT-PCR analysis confirmed that CD4 mRNA is detectable in WT but not mutant DN4 cells (Fig. 4 B, bottom).
###end p 43
###begin p 44
###xml 14 17 14 17 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CD4</italic>
###xml 112 115 112 115 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CD4</italic>
###xml 272 275 272 275 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CD4</italic>
###xml 326 327 326 327 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 412 415 412 415 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CD4</italic>
###xml 428 431 428 431 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Brg</italic>
###xml 455 458 451 454 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Brg</italic>
###xml 493 495 485 487 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib25">25</xref>
###xml 576 579 568 571 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Brg</italic>
###xml 579 582 571 574 <sup xmlns:xlink="http://www.w3.org/1999/xlink">F/F</sup>
###xml 651 652 643 644 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 667 670 659 662 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Brg</italic>
###xml 683 691 671 679 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig4" ref-type="fig">Fig. 4 C</xref>
###xml 756 757 744 745 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 770 773 758 761 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Brg</italic>
###xml 794 802 778 786 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig4" ref-type="fig">Fig. 4 C</xref>
###xml 815 823 799 807 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig4" ref-type="fig">Fig. 4 A</xref>
###xml 856 857 840 841 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 438 442 <span type="species:ncbi:10090|species:ncbi:10095">mice</span>
###xml 465 469 <span type="species:ncbi:10090|species:ncbi:10095">mice</span>
###xml 487 491 <span type="species:ncbi:10090|species:ncbi:10095">mice</span>
###xml 584 588 <span type="species:ncbi:10090|species:ncbi:10095">mice</span>
###xml 677 681 <span type="species:ncbi:10090|species:ncbi:10095">mice</span>
###xml 780 784 <span type="species:ncbi:10090|species:ncbi:10095">mice</span>
The defect in CD4 transcription in Brg-deleted DN4 cells suggests that Brg is required for the functions of the CD4 promoter/enhancer/LCR. However, this "transcription defect" might be an artifact resulting from a failure to inactivate the silencer. In this scenario, the CD4 silencer somehow remains active in Brg-deleted CD4-DN4 cells, thus blocking CD4 expression. To exclude this possibility, we deleted the CD4 silencer in Brg Delta mice by crossing Brg Delta mice with silencer KO mice (25). Silencer deletion significantly enhances CD4 expression in DN4 cells from WT (BrgF/F) mice, as expected, but indeed fails to rescue CD4 expression in CD4-DN4 cells from Brg Delta mice (Fig. 4 C, left). Of note, silencer deletion induces CD4 expression on CD4-DN3 cells in Brg Delta mice (compare Fig. 4 C, left, with Fig. 4 A, right), indicating that the CD4-DN3 cells are generated simply because Brg deletion cannot completely inactivate the silencer, and confirming that Brg is dispensable for CD4 expression in DN3 cells.
###end p 44
###begin p 45
###xml 156 159 156 159 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CD4</italic>
Collectively, the data show that Brg uses an ATPase-independent activity to increase the probability of CD4 expression in DN4 cells; in the absence of Brg, CD4 transcription in DN4 cells becomes variegated, with only a subset of DN4 cells expressing CD4. Furthermore, this variegated expression pattern, once established, seems epigenetically stable, surviving in vitro culture for at least 3 d (unpublished data).
###end p 45
###begin title 46
###xml 14 17 14 17 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CD4</italic>
Brg binds the CD4 enhancer and LCR
###end title 46
###begin p 47
###xml 44 47 44 47 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CD4</italic>
###xml 97 100 97 100 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CD4</italic>
###xml 120 122 120 122 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib22">22</xref>
###xml 238 241 238 241 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CD4</italic>
###xml 442 445 442 445 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CD4</italic>
###xml 562 564 562 564 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib29">29</xref>
###xml 626 629 626 629 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CD4</italic>
###xml 678 681 678 681 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CD4</italic>
###xml 725 728 725 728 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 769 772 769 772 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Brg</italic>
###xml 780 788 780 788 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig4" ref-type="fig">Fig. 4 D</xref>
###xml 858 861 858 861 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CD4</italic>
###xml 904 907 904 907 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CD4</italic>
###xml 930 938 930 938 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig4" ref-type="fig">Fig. 4 D</xref>
###xml 1016 1019 1016 1019 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CD4</italic>
###xml 1065 1073 1065 1073 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig4" ref-type="fig">Fig. 4 D</xref>
###xml 1163 1166 1163 1166 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Brg</italic>
###xml 1206 1214 1202 1210 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig4" ref-type="fig">Fig. 4 D</xref>
###xml 1276 1279 1272 1275 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CD4</italic>
###xml 1329 1332 1325 1328 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CD4</italic>
###xml 729 733 <span type="species:ncbi:10090|species:ncbi:10095">mice</span>
###xml 774 778 <span type="species:ncbi:10090|species:ncbi:10095">mice</span>
###xml 991 995 <span type="species:ncbi:10090|species:ncbi:10095">mice</span>
###xml 1173 1177 <span type="species:ncbi:10090|species:ncbi:10095">mice</span>
###xml 1200 1204 <span type="species:ncbi:10090|species:ncbi:10095">mice</span>
We have previously shown that Brg binds the CD4 silencer, suggesting that Brg directly regulates CD4 silencer function (22). To explore how Brg stimulates CD4 expression, we analyzed Brg binding to the positive regulatory elements at the CD4 locus. Chromatin from various cell types was immunoprecipitated with an anti-Brg antibody and the DNA was analyzed by two sets of PCR. The first is a multiplex PCR that coamplifies sequences from the CD4 enhancer, promoter, and silencer together with a fragment from the GAPDH gene, which serves as an internal control (29). The second is a duplex PCR coamplifying sequences from the CD4 LCR and GAPDH genes. As expected, Brg binds the CD4 silencer in DN (mostly DN3) cells from Rag2-/- mice, and in DN (mostly DN4) cells from Brg* mice (Fig. 4 D, top, lanes 1 and 4). Remarkably, in these cells, Brg also binds the CD4 enhancer and LCR, although binding to the CD4 promoter is marginal (Fig. 4 D, lanes 1 and 4). Interestingly, in DP cells from WT mice, Brg binds all four CD4 regulatory elements, including the promoter (Fig. 4 D, lane 2). The binding is specific because the signals were undetectable in DN cells from Brg Delta mice or in B cells from WT mice (Fig. 4 D, lanes 3, 5, and 6). These data suggest that Brg facilitates CD4 transcription in DN4 cells by directly acting on CD4 enhancer/LCR.
###end p 47
###begin title 48
###xml 28 31 28 31 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CD4</italic>
Effects of Brg mutations on CD4 enhancer/LCR accessibility
###end title 48
###begin p 49
###xml 72 75 72 75 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CD4</italic>
###xml 181 184 181 184 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CD4</italic>
###xml 252 255 252 255 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CD4</italic>
###xml 409 412 409 412 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CD4</italic>
###xml 568 571 568 571 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CD4</italic>
###xml 736 744 736 744 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig4" ref-type="fig">Fig. 4 E</xref>
###xml 798 801 798 801 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CD4</italic>
###xml 855 856 855 856 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 894 895 894 895 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 1008 1009 1008 1009 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 1020 1028 1020 1028 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig4" ref-type="fig">Fig. 4 E</xref>
###xml 1143 1146 1143 1146 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CD4</italic>
We have begun to explore the molecular mechanism whereby Brg stimulates CD4 transcription. Our genetic data indicate that Brg uses a novel, ATPase-independent activity to stimulate CD4 transcription, which predicts that Brg-dependent remodeling of the CD4 enhancer/LCR, if any, is not relevant to the functions of these elements. To confirm this, we used restriction enzymes to probe the accessibility of the CD4 regulatory elements. Brg mutations strongly reduce the silencer accessibility (unpublished data), as expected from the essential role of the Brg ATPase in CD4 silencer function. In contrast, Brg mutations do not affect the LCR accessibility, suggesting that Brg-dependent remodeling does not play any role in LCR function (Fig. 4 E, right). Although Brg mutations do moderately reduce CD4 enhancer accessibility, the extent of decrease in CD4-DN4 cells is comparable to that in CD4+ DN4 cells, suggesting that the accessibility decrease cannot explain the selective loss of CD4 expression in CD4-DN4 cells (Fig. 4 E, left). These data are consistent with the idea that ATP-dependent remodeling is dispensable for Brg to stimulate CD4 transcription.
###end p 49
###begin title 50
DISCUSSION
###end title 50
###begin p 51
###xml 461 464 461 464 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CD4</italic>
###xml 650 653 648 651 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CD4</italic>
###xml 35 39 <span type="species:ncbi:10090|species:ncbi:10095">mice</span>
###xml 147 151 <span type="species:ncbi:10090|species:ncbi:10095">mice</span>
We have developed a method whereby mice with a thymocyte-specific point mutation in the Brg ATPase domain are generated within the same litters as mice deleting Brg in thymocytes. Brg point mutation recapitulates multiple defects produced by Brg deletion but unexpectedly alters CD25 expression and is far more effective in derepressing CD4 than Brg deletion. Further analysis indicates that Brg not only represses CD4 in DN cells but also ensures the onset of CD4 transcription during DN-->DP transition; the latter effect, obscured in the Brg deletion mutant, is ATPase independent and perhaps mediated by physical interactions between Brg and the CD4 locus. This is the first demonstration that the ATPase-dead Brg point mutant, at a physiological concentration, is able to activate an endogenous gene. Our study thus proves that the BAF complex indeed harbors a novel activity in gene regulation distinct from ATP-dependent remodeling, the hallmark function of the BAF complex. Furthermore, it reveals that this activity is sufficient to regulate at least one target gene in the absence of Brg-dependent remodeling, which is counterintuitive given that endogenous genes are chromatinized. Our data highlight the complexity in the mechanisms of gene regulation in vivo, and raise the exciting possibility that the novel activities of the BAF complex might be widely involved in the regulation of BAF target genes, although by themselves such activities in general appear insufficient for gene regulation without concomitant Brg-dependent remodeling. Collectively, our study illustrates the power of conditional point mutations, rarely used in mammalian genetics, for dissecting and discovering gene functions. The strategy for simultaneous generation of deletion and point mutants is generally applicable to other genes.
###end p 51
###begin title 52
Deletion versus point mutation
###end title 52
###begin p 53
###xml 306 309 306 309 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CD4</italic>
Protein functions are typically studied by deleting the gene encoding the protein. This approach has several limitations. A protein often has multiple functions. Deletion abolishes all the functions, which may produce complex phenotypes, thus obscuring certain defects, such as the positive role of Brg in CD4 regulation. On the other hand, some defects may be masked by the redundant action of a related protein. Such a scenario could potentially explain why Brg point mutation (but not Brg deletion) enhances CD25 expression, assuming that the Brg homologue Brm could compensate for Brg to repress CD25.
###end p 53
###begin p 54
###xml 648 650 644 646 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib30">30</xref>
###xml 1050 1052 1046 1048 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib31">31</xref>
###xml 1054 1056 1050 1052 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib32">32</xref>
###xml 1441 1443 1437 1439 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib33">33</xref>
###xml 1445 1447 1441 1443 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib34">34</xref>
###xml 1677 1678 1673 1674 <sub xmlns:xlink="http://www.w3.org/1999/xlink">A</sub>
###xml 1687 1689 1683 1685 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib35">35</xref>
###xml 1734 1735 1730 1731 <sub xmlns:xlink="http://www.w3.org/1999/xlink">A</sub>
###xml 573 577 <span type="species:ncbi:10090|species:ncbi:10095">mice</span>
###xml 1561 1565 <span type="species:ncbi:10090|species:ncbi:10095">mice</span>
These limitations in deletion analysis may be overcome by introducing point mutations into relevant regions of the gene, because point mutations are more specific, and the mutant protein may act as a dominant negative to prevent the related protein from masking the phenotypes. Point mutations may help uncover protein functions via other mechanisms. For example, a point mutation at serine 276 in the p65 subunit of NF-kappab, which prevents p65 phosphorylation but does not affect its DNA binding, produces developmental defects distinct from those seen in p65 knock-out mice, thus providing unique insights into the biological functions of p65 (30). As in the case of deletion mutations, it is often desirable to introduce point mutations in a tissue-specific manner, but the technology for making such point mutations has not been well established. Before this work, three approaches were proposed to generate such mutations. The first two rely on Cre-mediated excision of an inverted, mutated exon that turns a WT allele into the mutant allele (31, 32). In each case, mutant LoxP sites that enable unidirectional recombination are used. An advantage of these methods is that the mutation can be introduced anywhere in the gene. The disadvantages are that inserting the inverted exon may interfere with the expression of the WT gene, and that Cre-mediated recombination of the mutant LoxP sites may not be as efficient as WT loxP sites (33, 34). So far, no publications describing the successful use of these methods for generating conditional point mutant mice have appeared. The third strategy has been successfully used to introduce mutations into the 3' end of the GABAA-R gene (35). In this method, the 3' portion of the GABAA-R gene that encompasses the site to be mutated is floxed, and a mutated version of this portion is duplicated and placed downstream of the endogenous locus. This mutant segment is transcriptionally silent until unmasked by Cre-mediated excision of the WT segment, where the mutant segment replaces the WT counterpart in the targeted gene. Whether this method can be used to introduce mutations elsewhere in the gene remains to be demonstrated.
###end p 54
###begin p 55
###xml 336 339 336 339 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Brg</italic>
Our method has several useful features. First, mutations can be introduced anywhere in the gene. Second, the status of the bi-functional allele can theoretically be monitored using the GFP engineered in the gene-trapping cassette, which should facilitate phenotypic analysis. Although we failed to detect GFP expression in the targeted Brg allele, we believe this is caused by the use of the destabilized version of GFP. Indeed, we have introduced a gene-trapping cassette expressing a regular GFP into the BAF57 gene encoding another subunit of the BAF complex and were able to visualize GFP in the targeted ES clones (unpublished data). The last feature is that our strategy can generate deletion and point mutants within the same litters, allowing for the direct comparison of phenotypes. A drawback of our strategy is that two different alleles (i.e., a floxed and a bifunctional allele) must be generated to reveal the effects of the point mutation, as opposed to the aforementioned methods that only need one conditional allele. Finally, the genes being targeted must be haplosufficient for embryogenesis. However, given that traditional floxed alleles have already been made for numerous genes, many of which are haplosufficient for embryogenesis, our strategy should be widely useful.
###end p 55
###begin title 56
###xml 32 35 32 35 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CD4</italic>
Dual role of the BAF complex in CD4 regulation
###end title 56
###begin p 57
###xml 87 88 87 88 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib8">8</xref>
###xml 90 91 90 91 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib9">9</xref>
###xml 287 293 287 293 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig5" ref-type="fig">Fig. 5</xref>
###xml 315 318 315 318 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CD4</italic>
###xml 515 518 515 518 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CD4</italic>
###xml 725 728 725 728 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CD4</italic>
###xml 890 893 890 893 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CD4</italic>
###xml 946 949 946 949 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CD4</italic>
###xml 1164 1167 1164 1167 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CD4</italic>
We and others previously showed that Brg deletion disrupts CD4 repression in DN cells (8, 9). Unexpectedly, Brg point mutation is more effective in derepressing CD4 than the Brg deletion, which led to the discovery of the dual roles of Brg in CD4 regulation, as proposed in the model in Fig. 5. In DN1-3 cells, the CD4 promoter is completely inhibited by the fully active silencer. In DN4 cells, the silencer is presumably beginning to be inactivated by a physiological mechanism not involving Brg, thus initiating CD4 transcription that culminates in full-blown CD4 expression in DP cells. Brg is required for CD4 silencer function in DN3 and 4, and presumably also in DN1 and 2 cells. Brg also increases the probability of CD4 transcriptional initiation in DN4 cells. Thus, Brg deletion produces conflicting effects in DN4 cells: it facilitates CD4 derepression by helping inactivate the CD4 silencer while stochastically blocking the onset of CD4 transcription, leading to a variegated CD4 expression pattern that seems epigenetically stable once established. CD4 repression by Brg requires its ATPase, whereas an ATPase-independent activity is used to promote CD4 transcription.
###end p 57
###begin p 58
###xml 32 35 32 35 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CD4</italic>
###xml 0 47 0 47 <bold xmlns:xlink="http://www.w3.org/1999/xlink">A model for the roles of Brg in <italic>CD4</italic> regulation.</bold>
###xml 176 179 176 179 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CD4</italic>
###xml 308 311 308 311 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CD4</italic>
###xml 403 406 403 406 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CD4</italic>
A model for the roles of Brg in CD4 regulation. T cells develop from DN to DP cells. CD4 expression (red dots), first detected in DN4 cells, is controlled by the silencer (S), CD4 promoter (P), enhancer (E), and LCR (L). For simplicity, the silencer is depicted to be located upstream of, and to act on, the CD4 promoter (top), but the exact mechanism of repression is unknown. Brg plays a dual role in CD4 regulation in DN cells by acting on both the silencer and enhancer/LCR, using distinct biochemical activities (bottom). Brg binds these elements, but it remains to be seen whether this interaction is functionally relevant.
###end p 58
###begin p 59
###xml 21 24 21 24 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CD4</italic>
###xml 40 43 40 43 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CD4</italic>
###xml 352 355 352 355 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CD4</italic>
###xml 527 530 527 530 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CD4</italic>
###xml 572 578 572 578 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig5" ref-type="fig">Fig. 5</xref>
###xml 962 966 <span type="species:ncbi:10090|species:ncbi:10095">mice</span>
###xml 1107 1111 <span type="species:ncbi:10090|species:ncbi:10095">mice</span>
How does Brg repress CD4? Brg binds the CD4 silencer, where it uses the ATPase to remodel the chromatin and facilitates the entry of Runx1, a transcription repressor essential for CD4 inhibition in DN cells, and this effect might be responsible for CD4 repression (unpublished data). The mechanism for positive CD4 regulation is unclear. Brg binds the CD4 enhancer and LCR, suggesting that the BAF complex acts directly on these elements, but future experiments are needed to prove this; it is possible that Brg binding at the CD4 enhancer/LCR is functionally irrelevant (Fig. 5). For example, Brg may act instead by stimulating the expression of a transcription activator required for efficient CD4 expression. Interestingly, Brg is dispensable for CD4 expression in DN3 cells, indicating that a distinct mechanism is used to ensure uniform CD4 expression in these cells. Brg also seems dispensable for CD4 expression in DP cells, because DP cells in Brg Delta mice show uniform, high level CD4 expression. The role of Brg in CD4 regulation in ISP cells is unknown; ISP cells are undetectable in Brg Delta mice apparently because they have lost CD8 expression.
###end p 59
###begin p 60
###xml 121 124 121 124 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Brg</italic>
###xml 124 127 124 127 <sup xmlns:xlink="http://www.w3.org/1999/xlink">O/+</sup>
###xml 133 136 133 136 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/&#8722;</sup>
###xml 318 319 318 319 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 322 323 322 323 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 137 141 <span type="species:ncbi:10090|species:ncbi:10095">mice</span>
Finally, we note that the effectiveness of Brg point mutation in CD4 derepression may explain the "loss" of DN4 cells in BrgO/+; Cre +/- mice. Presumably, Brg (K/R) has interfered with WT Brg protein, leading to premature CD4 expression on DN4 cells, which subsequently leave the DN4 compartment and blend into the CD4+CD8- pool.
###end p 60
###begin title 61
MATERIALS AND METHODS
###end title 61
###begin title 62
###xml 38 42 <span type="species:ncbi:10090|species:ncbi:10095">mice</span>
DNA construct, ES cell targeting, and mice breeding.
###end title 62
###begin p 63
###xml 35 43 35 43 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig1" ref-type="fig">Fig. 1 B</xref>
###xml 332 334 332 334 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib36">36</xref>
###xml 336 338 336 338 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib37">37</xref>
###xml 698 701 698 701 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Brg</italic>
###xml 849 857 849 857 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig1" ref-type="fig">Fig. 1 C</xref>
###xml 1058 1059 1058 1059 <sub xmlns:xlink="http://www.w3.org/1999/xlink">V</sub>
###xml 1285 1288 1285 1288 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Brg</italic>
###xml 1288 1289 1288 1289 <sup xmlns:xlink="http://www.w3.org/1999/xlink">F</sup>
###xml 1459 1465 1459 1465 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig2" ref-type="fig">Fig. 2</xref>
###xml 1471 1474 1471 1474 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CD4</italic>
###xml 452 456 <span type="species:ncbi:10633?0.9966199903428296">SV40</span>
###xml 1177 1181 <span type="species:ncbi:10090|species:ncbi:10095">mice</span>
###xml 1268 1272 <span type="species:ncbi:10090|species:ncbi:10095">mice</span>
###xml 1414 1418 <span type="species:ncbi:10090|species:ncbi:10095">mice</span>
###xml 1493 1497 <span type="species:ncbi:10090|species:ncbi:10095">mice</span>
###xml 1571 1575 <span type="species:ncbi:10090|species:ncbi:10095">mice</span>
To make the construct described in Fig. 1 B, we first constructed a gene-trapping cassette consisting of the following: (a) a 120-bp fragment from pCEM MINX containing the adenovirus major late transcript splicing acceptor sequence from the intron 1/exon 2 boundary (a gift from S. Berget, Baylor College of Medicine, Houston, TX) (36, 37); (b) the neomycin resistant gene; (c) IRES; (d) the hr GFP (Stratagene) fused to the PEST sequence; and (e) the SV40 poly A sequence. We then floxed this cassette by inserting it into pEasy Lox (a gift from K. Rajewsky, Harvard University, Cambridge, MA), replacing the PGK-Neo-poly A-LoxP sequence in the original vector. Finally, we inserted PCR-amplified Brg genomic sequences upstream and downstream of the loxP sites to create the left and right arms, respectively. The left arm contains the exon (E2 in Fig. 1 C) encoding lysine 785, and this residue was mutated to arginine. The cloned fragments were sequenced in their entirety and no PCR-introduced error was found. The construct was electroporated into 129/SV ES cells and correctly targeted ES cells identified by RT-PCR. An ES clone was injected into blastocysts from C57B/6 mice to generate chimeras carrying the bifunctional allele. The founders were crossed with mice bearing the BrgF allele, and the LCK-Cre and LCK-Bcl-xL transgenes (gifts from C. Wilson, University of Washington, Seattle, WA) to generate mice with various genotypes, as described in Fig. 2. The CD4 silencer knockout mice were provided by D. Littman (New York University, New York, NY). All the mice were on mixed genetic backgrounds, and experiments were performed according to the guidelines from Yale University's Institutional Animal Care and Use Committee.
###end p 63
###begin title 64
Flow cytometry.
###end title 64
###begin p 65
###xml 66 67 66 67 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib8">8</xref>
###xml 583 584 583 584 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib8">8</xref>
###xml 523 527 <span type="species:ncbi:10090|species:ncbi:10095">mice</span>
Flow cytometrical analysis was performed as previously described (8), except that the samples were analyzed on LSRII (BD) at Yale University, which necessitated minor modifications in the staining schemes. In brief, to analyze CD4/CD8 expression in various subsets of thymocytes, cells were stained with anti-CD4-allophycocyanin (APC), anti-CD8-PE-Cy7, anti-CD25-FITC, anti-CD44-PE, and anti-CD3-Cy5, and the cells were analyzed as described in Results. To assay cell proliferation, BrdU was injected intraperitoneally and mice were killed 15 min afterward, as previously described (8). Cells were stained with anti-CD4-Alexa Fluor 680, anti-CD8-PE-Cy7, anti-CD25-APC, anti-CD44-PE, and anti-BrdU-FITC before analysis.
###end p 65
###begin title 66
PCR, Western blotting, and RT-PCR analysis of thymocytes.
###end title 66
###begin p 67
###xml 4 7 4 7 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Brg</italic>
###xml 7 8 7 8 <sup xmlns:xlink="http://www.w3.org/1999/xlink">O</sup>
###xml 13 16 13 16 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Brg</italic>
###xml 16 17 16 17 <sup xmlns:xlink="http://www.w3.org/1999/xlink">F</sup>
###xml 123 131 123 131 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig1" ref-type="fig">Fig. 1 C</xref>
###xml 240 243 240 243 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Brg</italic>
###xml 243 244 243 244 <sup xmlns:xlink="http://www.w3.org/1999/xlink">O</sup>
###xml 273 276 273 276 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CD4</italic>
###xml 344 347 344 347 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Brg</italic>
###xml 347 348 347 348 <sup xmlns:xlink="http://www.w3.org/1999/xlink">F</sup>
###xml 359 362 359 362 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Brg</italic>
###xml 362 365 362 365 <sup xmlns:xlink="http://www.w3.org/1999/xlink">F/F</sup>
###xml 407 410 407 410 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CD4</italic>
###xml 487 490 487 490 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Brg</italic>
###xml 490 491 490 491 <sup xmlns:xlink="http://www.w3.org/1999/xlink">F</sup>
###xml 502 505 502 505 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Brg</italic>
###xml 505 508 505 508 <sup xmlns:xlink="http://www.w3.org/1999/xlink">F/O</sup>
###xml 627 630 627 630 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Brg</italic>
###xml 710 713 710 713 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Brg</italic>
###xml 713 714 713 714 <sup xmlns:xlink="http://www.w3.org/1999/xlink">F</sup>
###xml 735 738 735 738 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Brg</italic>
###xml 738 739 738 739 <sup xmlns:xlink="http://www.w3.org/1999/xlink">O</sup>
###xml 1378 1381 1378 1381 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Brg</italic>
###xml 1381 1384 1381 1384 <sup xmlns:xlink="http://www.w3.org/1999/xlink">F/F</sup>
###xml 1391 1399 1391 1399 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig4" ref-type="fig">Fig. 4 B</xref>
###xml 1437 1438 1437 1438 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 381 385 <span type="species:ncbi:10090|species:ncbi:10095">mice</span>
###xml 524 528 <span type="species:ncbi:10090|species:ncbi:10095">mice</span>
###xml 1385 1389 <span type="species:ncbi:10090|species:ncbi:10095">mice</span>
The BrgO and BrgF alleles in thymocytes were monitored by PCR using primer pairs b/c and h/i, respectively, as depicted in Fig. 1 C; these primers can only recognize the parental allele and not the recombination products. For detecting the BrgO allele, a fragment from the CD4 enhancer was coamplified as an internal control. For detecting the BrgF allele in BrgF/F; Cre; (Bcl-xL) mice, a fragment from the CD4 silencer was coamplified as an internal control. However, for detecting the BrgF allele in BrgF/O; Cre; (Bcl-xL) mice, the h/i primer pair alone is sufficient, because the primer pair, which binds the regions in the Brg gene flanking the 3' LoxP site (placed downstream of E4), not only detects the BrgF allele but also the BrgO allele before or after its conversion, with the latter therefore serving as an internal control because its amplification efficiency is not affected by Cre-mediated conversion. Western blotting was performed using an anti-Brg antibody from Millipore. For semiquantitative RT-PCR, total RNA was extracted using the RNAeasy kit (QIAGEN) and analyzed using a one-step RT-PCR master mix (Invitrogen). For quantitative RT-PCR, the mRNA was first reverse-transcribed into cDNA and then quantified using Quantitect qPCR mix (QIAGEN). DN3, DN4, and DP cells from the Brg mutants were directly sorted from total thymocytes. DN3 and DN4 cells from BrgF/F mice (Fig. 4 B) were first enriched by depleting CD8+ cells with magnetic beads, followed by their purification via cell sorting. The purity of the sorted cells exceeded 90% (not depicted).
###end p 67
###begin title 68
Chromatin immunoprecipitation.
###end title 68
###begin p 69
###xml 32 35 32 35 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Brg</italic>
###xml 386 389 386 389 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Brg</italic>
###xml 440 448 440 448 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig3" ref-type="fig">Fig. 3 A</xref>
###xml 483 486 483 486 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Brg</italic>
###xml 541 542 537 538 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 550 551 546 547 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 757 760 749 752 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 886 888 878 880 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib29">29</xref>
###xml 37 41 <span type="species:ncbi:10090|species:ncbi:10095">mice</span>
###xml 391 395 <span type="species:ncbi:10090|species:ncbi:10095">mice</span>
###xml 493 497 <span type="species:ncbi:10090|species:ncbi:10095">mice</span>
###xml 706 710 <span type="species:ncbi:10090|species:ncbi:10095">mice</span>
###xml 761 765 <span type="species:ncbi:10090|species:ncbi:10095">mice</span>
Thymocytes at the DN stage from Brg* mice were isolated by negative selection with biotin-anti-CD8/CD3 antibodies and streptavidin magnetic beads (BD), which removed DP and residual SP cells. The majority (>90%) of the isolated cells were DN4 cells, with the remaining being DN1-3 cells. It is not feasible to deplete the DN2 and 3 cells using anti-CD25 beads, because the DN4 cells in Brg* mice express low to intermediate levels of CD25 (Fig. 3 A). Thymocytes at the DN stage from Brg Delta mice were similarly isolated except that the CD4+ and CD4- cells were further separated using anti-CD4 beads; these cells were also predominantly at the DN4 stage. B cells were magnetically purified from WT (CD1) mice, with purity >90%. DP cells were from TCRalpha-/- mice. Chromatin was fixed, sheared, precleared, immunoprecipitated, and analyzed by PCR essentially as previously described (29); the Brg antibody was from Millipore.
###end p 69
###begin title 70
Restriction enzyme accessibility assay.
###end title 70
###begin p 71
###xml 82 84 82 84 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib38">38</xref>
The restriction enzyme accessibility assay was performed as previously described (38). In brief, 0.2 million lymphocytes were digested with restriction enzymes in 10 mul 1x NEB digestion buffer II in the presence of 0.1% NP-40, which permeabilizes the membrane. After the digestion, the reaction was heated to 80degreesC for 20 min to inactivate the enzyme. 1 mul proteinase K (10 mug) was added and the sample was digested overnight at 50degreesC. The sample was then heated to 80degreesC for 20 min, and PMSF was added to 0.1 mM to completely inactivate proteinase K. DNA was directly digested with 0.3 mul of a second enzyme for 3 h, and a mixture of linkers recognizing the first and second cuts was added together with 0.3 mul NEB T4 DNA ligase. The reaction was incubated at room temperature for 12 h before PCR analysis using 1 mul of ligated DNA. The amplicons were detected by primer extension using radiolabeled, nested primers. The amplicons were resolved on sequencing gels, and the intensity of the short relative to the long amplicons was taken as a measure of accessibility.
###end p 71
###begin title 72
Online supplemental material.
###end title 72
###begin p 73
###xml 49 52 49 52 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Brg</italic>
###xml 52 53 52 53 <sup xmlns:xlink="http://www.w3.org/1999/xlink">O</sup>
###xml 131 134 131 134 <sup xmlns:xlink="http://www.w3.org/1999/xlink">O/+</sup>
###xml 164 167 164 167 <sup xmlns:xlink="http://www.w3.org/1999/xlink">O/+</sup>
Fig. S1 A shows that alternative splicing in the BrgO allele is undetectable. Fig. S1 B shows that Brg mRNA level is reduced in BrgO/+thymocytes but restored in BrgO/+; Cre thymocytes. Online supplemental material is available at .
###end p 73
###begin title 74
Supplementary Material
###end title 74
###begin title 75
[Supplemental Material Index]
###end title 75
###begin p 76
###xml 70 73 70 73 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CD4</italic>
###xml 38 42 <span type="species:ncbi:10090|species:ncbi:10095">mice</span>
###xml 86 90 <span type="species:ncbi:10090|species:ncbi:10095">mice</span>
We thank Drs. C.B. Wilson for LCK-Cre mice, D. Littman and Y. Zou for CD4 silencer KO mice, S. Berget for the pCEM MINX plasmid, K. Rajewsky for the pEasy Lox plasmid, and P. Soriano for advice on gene trapping.
###end p 76
###begin p 77
This work is funded by the National Institutes of Health (grant R01AI063554-02 to T. Chi), the Anna Fuller Foundation (to A. Jani), and the Intramural Research Program of the National Heart, Lung, and Blood Institute/National Institutes of Health (K. Zhao).
###end p 77
###begin p 78
The authors have no conflicting financial interests.
###end p 78

